{"text": "Based on the existing controlled trial evidence , researchers have concluded that moxifloxacin is as effective or even more effective compared with other antimicrobials , with a more advantageous dosage regimen that may be associated with increased compliance [ 27 , 28 ] .", "label": "", "metadata": {}, "score": "20.64014"}
{"text": "[ PubMed 16323095 ] .Welte T , Petermann W , Schurmann D et al .Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community - acquired pneumonia who received initial parenteral therapy .", "label": "", "metadata": {}, "score": "24.03737"}
{"text": "Patients receiving oral or IV moxifloxacin should be well hydrated and instructed to drink fluids liberally .Oral Administration .Administer tablets orally without regard to meals . 1 ( See Pharmacokinetics . )", "label": "", "metadata": {}, "score": "25.05262"}
{"text": "However , the frequency of such treatments did not differ between the treatment arms and benefit with moxifloxacin was seen in subgroups receiving such concomitant treatment .", "label": "", "metadata": {}, "score": "25.341444"}
{"text": "Safety assessments .Moxifloxacin treatment was interrupted in eight of these patients , withdrawn in four , and the dose was reduced in one patient .", "label": "", "metadata": {}, "score": "25.697807"}
{"text": "Physicians rated the tolerability of moxifloxacin as ' very good or good ' in approximately 98 % of patients , similar to the rate ( 97 % ) reported in the observational study by Miravitlles et al .", "label": "", "metadata": {}, "score": "26.566212"}
{"text": "The efficacy , safety , and tolerability profiles of moxifloxacin that are characterized in this large observational study from South Eastern / Eastern Europe confirm previous studies which report that moxifloxacin offers benefits for the treatment of moderate - to - severe exacerbations in outpatients with AECB .", "label": "", "metadata": {}, "score": "26.94276"}
{"text": "All prescribing choices were made by physicians .As approximately 16 % of patients who received moxifloxacin were classified with Anthonisen type III AECB , antibiotic therapy was not prescribed in accordance with current guidelines in all circumstances .", "label": "", "metadata": {}, "score": "27.418201"}
{"text": "In addition , the time until next exacerbation was significantly greater with moxifloxacin than the comparator during 9-month follow - up [ 22 ] , which may be attributed to more effective bacterial eradication by moxifloxacin [ 23 ] .", "label": "", "metadata": {}, "score": "27.4872"}
{"text": "This suggests that physicians considered the recommended dose of moxifloxacin to be highly effective , without the need to adjust the dose , e.g. for body weight .", "label": "", "metadata": {}, "score": "27.821796"}
{"text": "No differences in the efficacy of moxifloxacin were observed between patients either without or with a diverse range of comorbidities .Unlike in clinical trials , the dosing regimen used in this non - interventional study was left to the sole discretion of the treating physician .", "label": "", "metadata": {}, "score": "28.021824"}
{"text": "The mean duration of moxifloxacin therapy for the current exacerbation ( Anthonisen type I or II in 83.1 % ; predominantly type I ) was 6.4 \u00b1 1.9 days .", "label": "", "metadata": {}, "score": "28.354136"}
{"text": "IV Infusion .Premixed injection for IV infusion containing 400 mg of moxifloxacin in 0.8 % sodium chloride injection in single - use flexible container may be used without further dilution .", "label": "", "metadata": {}, "score": "28.368011"}
{"text": "Finally , for patients with available data , physicians compared the overall effect and onset of action of moxifloxacin against the antibiotic used to treat the previous episode of AECB .", "label": "", "metadata": {}, "score": "28.459988"}
{"text": "Discussion .Intermittent prophylactic pulsed treatment with moxifloxacin resulted in a 19 % reduction in the odds of exacerbation in the ITT population and a 25 % reduction in the PP EOT population in this study .", "label": "", "metadata": {}, "score": "28.506138"}
{"text": "PRECAUTIONS .General .Prescribing moxifloxacin tablets and oral suspension in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug - resistant bacteria .", "label": "", "metadata": {}, "score": "28.6982"}
{"text": "The rapid recovery from symptoms observed in this study is a desirable characteristic of an effective treatment for patients with AECB .Other observational and controlled studies and cross - sectional analyses report that moxifloxacin is associated with a more rapid recovery from symptoms than other commonly used treatments [ 31 - 33 ] .", "label": "", "metadata": {}, "score": "28.783052"}
{"text": "Pre - specified subgroup analyses demonstrated that the reduction in exacerbations with moxifloxacin was seen in COPD of all severity categories , among smokers and ex - smokers , and in patients receiving concomitant COPD treatments including inhaled steroids and long - acting bronchodilators .", "label": "", "metadata": {}, "score": "28.813816"}
{"text": "Moxifloxacin was considered to have an earlier onset of action compared with the previous antibiotic in 73.5 % of patients , equivalent onset in 9.5 % , and later onset in 1.3 % , with missing data in 15.7 % .", "label": "", "metadata": {}, "score": "28.857065"}
{"text": "Physicians additionally provided summary assessments of the overall efficacy and tolerability of moxifloxacin into the categories : ' very good ' , ' good ' , ' sufficient ' , and ' insufficient ' .", "label": "", "metadata": {}, "score": "29.277805"}
{"text": "Mean duration of treatment until symptom improvement in patients with concomitant diseases is described in Table 4 .For patients with COPD ( diagnosed by the attending physician ) , the mean duration of moxifloxacin treatment until improvement was 3.5 \u00b1 1.4 days .", "label": "", "metadata": {}, "score": "29.8908"}
{"text": "The observational study by Miravitlles et al .[29 ] reported similarly low rates of treatment - related withdrawal ( 0.6 % ) .The overall satisfaction with moxifloxacin treatment expressed by both physicians and patients was high .", "label": "", "metadata": {}, "score": "30.10961"}
{"text": "Ann Surg .[ PubMed 16858182 ] .Sullivan JT , Woodruff M , Lettieri J et al .Pharmacokinetics of a once - daily oral dose of moxifloxacin ( Bay 12 - 8039 ) , a new enantiomerically pure 8-methoxy quinolone .", "label": "", "metadata": {}, "score": "30.722584"}
{"text": "Footnotes .P- Reviewer Butterworth J S- Editor Gou SX L- Editor O'Neill M E- Editor ZhangDN .References .Felisart J , Rimola A , Arroyo V , Perez - Ayuso RM , Quintero E , Gines P , Rodes J. Cefotaxime is more effective than is ampicillin - tobramycin in cirrhotics with severe infections .", "label": "", "metadata": {}, "score": "30.97898"}
{"text": "Advise patients that peripheral neuropathies have been reported with moxifloxacin and that symptoms may occur soon after initiation of the drug and may be irreversible .", "label": "", "metadata": {}, "score": "31.298939"}
{"text": "The high response rate in this study , which included patients with a range of common comorbidities , suggests that treatment with broader - spectrum drugs such as moxifloxacin is appropriate for patients with moderate - to - severe AECB who are managed outside hospital .", "label": "", "metadata": {}, "score": "31.397581"}
{"text": "Extended description of the protocol , including information not already contained in other fields .Objective : To compare 400 mg of oral moxifloxacin ( Oral Group ) once daily to 2 grams of IV cefazolin and 1 gram of oral probenecid once daily ( IV group ) for the treatment of moderate cellulitis .", "label": "", "metadata": {}, "score": "31.517965"}
{"text": "Importance of taking moxifloxacin at least 4 hours before or 8 hours after multivitamins or dietary supplements containing iron or zinc ; aluminum- or magnesium - containing antacids ; or buffered didanosine ( pediatric oral solution admixed with antacid ) .", "label": "", "metadata": {}, "score": "31.736023"}
{"text": "The results of this study are in agreement with previous studies of moxifloxacin treatment in patients with AECB , including the international observational GIANT study , where symptom improvement occurred after a mean of 3.4 days [ 29 ] .", "label": "", "metadata": {}, "score": "31.894176"}
{"text": "An IV antipneumococcal , antipseudomonal beta - lactam + ( ciprofloxacin IV [ 400 mg q8 - 12h ] or levofloxacin IV 750 mg / day ) ( BIII ) .", "label": "", "metadata": {}, "score": "31.914997"}
{"text": "TMP / SMX is the preferred prophylactic agent , at a dose of one double - strength tablet daily .In addition to its proven efficacy and low cost , TMP / SMX reduces the incidence of toxoplasmosis and bacterial infections .", "label": "", "metadata": {}, "score": "31.967556"}
{"text": "Final decisions on the dose of moxifloxacin and on the use of concomitant medications were at the discretion of the attending physician .Efficacy and safety assessments .", "label": "", "metadata": {}, "score": "32.845818"}
{"text": "Few data exist on the outpatient antibiotic management of AECB / AECOPD in Eastern / South Eastern Europe , and in particular on the use of moxifloxacin in this population .", "label": "", "metadata": {}, "score": "33.0402"}
{"text": "The purpose of this study is to determine if treatment of moderate cellulitis with an intravenous antibiotic ( cefazolin ) for 3 - 5 days is as effective as treatment with an oral antibiotic ( moxifloxacin ) .", "label": "", "metadata": {}, "score": "33.497787"}
{"text": "[ PubMed 16675781 ] .Codecasa LR , Ferrara G , Ferrarese M et al .Long - term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs .", "label": "", "metadata": {}, "score": "33.56446"}
{"text": "Respir Med 2000 , 94 ( 1 ) : 18 - 27 .PubMed View Article .Miravitlles M , Molina J , Brosa M : Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis : a systematic review and meta - analysis [ in Spanish].", "label": "", "metadata": {}, "score": "33.594734"}
{"text": "Alternative Therapy : For Penicillin - Allergic Patients : .Aztreonam ( IV ) + an IV respiratory fluoroquinolone ( moxifloxacin 400 mg per day or levofloxacin 750 mg per day ) ( BIII ) .", "label": "", "metadata": {}, "score": "34.052383"}
{"text": "Skin and Skin Structure Infections .Uncomplicated Infections .Complicated Infections .Intra - abdominal Infections .Complicated Infections .IV , then Oral .Initiate therapy with 400 mg IV once daily . 1 39 When appropriate , switch to oral moxifloxacin 400 mg once daily .", "label": "", "metadata": {}, "score": "34.220337"}
{"text": "The efficacy of moxifloxacin was rated by physicians as ' very good ' or ' good ' in 97.7 % of patients , ' sufficient ' in 1.8 % , and ' insufficient ' in 0.5 % .", "label": "", "metadata": {}, "score": "34.22055"}
{"text": "The extent of reduction in exacerbations in these patients is similar to that seen with long - acting bronchodilators and inhaled steroids in recent clinical trials in COPD [ 21 - 26 ] .", "label": "", "metadata": {}, "score": "34.529648"}
{"text": "Mild cases of pneumocystis may be treated on an outpatient basis with two double - strength tablets of TMP - SMX three times a day .", "label": "", "metadata": {}, "score": "34.661556"}
{"text": "An IV beta - lactam + IV azithromycin ( AII ) , or .An IV beta - lactam + ( levofloxacin a IV 750 mg once daily or moxifloxacin a 400 mg IV daily ) ( AII ) .", "label": "", "metadata": {}, "score": "35.00235"}
{"text": "Antibiotic chemoprophylaxis generally is not recommended specifically to prevent recurrences of bacterial respiratory infections because of the potential for development of drug - resistant microorganisms and drug toxicity .", "label": "", "metadata": {}, "score": "35.047554"}
{"text": "The tolerability of moxifloxacin was rated by physicians as ' very good ' or ' good ' in 97.8 % of patients , ' sufficient ' in 1.8 % , and ' insufficient ' in 0.3 % .", "label": "", "metadata": {}, "score": "35.09895"}
{"text": "Chodosh S , DeAbate CA , Haverstock D , Aneiro L , Church D : Short - course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis .", "label": "", "metadata": {}, "score": "35.22592"}
{"text": "A switch to oral therapy should be considered in patients with CAP on IV antibiotic therapy who have improved clinically , can swallow and tolerate oral medications , and have intact gastrointestinal function .", "label": "", "metadata": {}, "score": "35.255394"}
{"text": "[ PubMed 16288390 ] .Morganroth J , DiMarco JP , Anzueto A et al .A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community - acquired pneumonia .", "label": "", "metadata": {}, "score": "35.39963"}
{"text": "Serious and occasionally fatal hypersensitivity and/or anaphylactic reactions reported in patients receiving fluoroquinolones , including moxifloxacin . 1Although generally reported after multiple doses , these reactions may occur with first dose .", "label": "", "metadata": {}, "score": "35.47175"}
{"text": "[ PubMed 16304291 ] .Fogarty C , Torres A , Choudhri S et al .Efficacy of moxifloxacin for treatment of penicillin- , macrolide- and multidrug - resistant Streptococcus pneumoniae in community - acquired pneumonia .", "label": "", "metadata": {}, "score": "35.63324"}
{"text": "Recent reports showed that resistance to third generation cephalosporins ( including cefotaxime ) is increasing [ 4 , 5 ] and this may increase the need to develop alternative antibiotics .", "label": "", "metadata": {}, "score": "35.879868"}
{"text": "Wilson R , Allegra L , Huchon G , Izquierdo JL , Jones P , Schaberg T , Sagnier PP , MOSAIC Study Group : Short - term and long - term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis .", "label": "", "metadata": {}, "score": "35.973553"}
{"text": "Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department .December 2012 ( Final data collection date for primary outcome measure ) .", "label": "", "metadata": {}, "score": "36.31227"}
{"text": "Wilson R , Allegra L , Huchon G , Izquierdo JL , Jones P , Schaberg T , Sagnier PP : Short - term and long - term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis .", "label": "", "metadata": {}, "score": "36.589714"}
{"text": "The efficacy of empiric antibiotic treatment can rarely be based on the amelioration of symptoms or on microbiological results .Therefore , a reduction of PMNL count below 250 cell / mm 3 or a 25 % reduction of the initial value has been suggested as the main criterion for establishing the efficacy of antibiotics and the need for switching therapy .", "label": "", "metadata": {}, "score": "36.62587"}
{"text": "PubMed View Article .Miravitlles M : Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD .Int J Chron Obstruct Pulmon Dis 2007 , 2 ( 3 ) : 191 - 204 .", "label": "", "metadata": {}, "score": "36.692726"}
{"text": "It is also a consideration for HIV - infected patients who use corticosteroids , are severely malnourished , have been hospitalized in the past 90 days or reside in a health care facility or nursing home , or are on chronic hemodialysis .", "label": "", "metadata": {}, "score": "36.740498"}
{"text": "Hospitalization for parenteral antibiotic therapy is recommended .Antibiotic Regimens .Recommended Oral / Outpatient Regimens .Ceftriaxone 250 mg IM in a single dose + doxycycline 100 mg PO BID for 14 days , with or without metronidazole 500 mg PO BID for 14 days .", "label": "", "metadata": {}, "score": "37.012924"}
{"text": "There were no serious adverse events .About INTUNIV .INTUNIV is currently being studied as a once - daily , extended release formulation of guanfacine designed to provide steady delivery of drug throughout the day .", "label": "", "metadata": {}, "score": "37.0214"}
{"text": "[ PubMed 16236076 ] .Burman WJ , Goldberg S , Johnson JL et al .Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis .", "label": "", "metadata": {}, "score": "37.205658"}
{"text": "In a routine clinical setting , where bacteriological assessment may not be available , empirical antibacterial therapy is generally recommended for patients who fulfill specific clinical criteria , with the aim to influence the disease course and prevent complications [ 10 - 12 ] .", "label": "", "metadata": {}, "score": "37.212254"}
{"text": "Trimetrexate ( 45 mg / m 2 IV daily ) plus leucovorin ( 20 mg / m 2 po q 6 hours ) .Corticosteroids should be given to patients with PCP who are hypoxic ( i.e. have a pO 2 less than 70 mm Hg or an alveolar - arterial pO 2 difference exceeding 35 mm Hg ) .", "label": "", "metadata": {}, "score": "37.309975"}
{"text": "There were no significant differences in mortality rates between moxifloxacin and placebo in either population or any subgroup .Lung function .Average lung function declined slightly during the study in both groups of patients .", "label": "", "metadata": {}, "score": "37.535343"}
{"text": "Relative potential of the various fluoroquinolones to cause photosensitivity / phototoxicity unclear .Avoid unnecessary or excessive exposure to sunlight or artificial UV light ( tanning beds , UVA / UVB treatment ) while receiving moxifloxacin .", "label": "", "metadata": {}, "score": "37.57911"}
{"text": "PubMed View Article .Wilson R , Kubin R , Ballin I , Deppermann KM , Bassaris HP , Leophonte P , Schreurs AJ , Torres A , Sommerauer B : Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis .", "label": "", "metadata": {}, "score": "37.635612"}
{"text": "PubMed View Article .Miravitlles M : Moxifloxacin : an antibiotic designed for use in the community .Eur Respir Rev 2000 , 10 : 161 - 169 .", "label": "", "metadata": {}, "score": "37.743935"}
{"text": "Treatment outcomes .The clinical and laboratory parameters of group II patients showed no major improvement with the initial empirical therapy ; whereas noticeable improvements in many of the parameters were achieved when the alterative antibiotic therapy was given .", "label": "", "metadata": {}, "score": "37.99339"}
{"text": "Recent reports showed that resistance to third generation cephalosporins ( including cefotaxime ) is increasing and this may increase the need to develop alternative antibiotics .", "label": "", "metadata": {}, "score": "38.07583"}
{"text": "Patients who are hospitalized for treatment initially may be switched to an oral regimen and be discharged on oral therapy after they have improved clinically .", "label": "", "metadata": {}, "score": "38.130016"}
{"text": "Table 3 .Course of symptoms during observational period ; patients with symptoms at initial visit ( efficacy population ) .Improvement in symptoms occurred after a mean of 3.4 \u00b1 1.4 days of moxifloxacin treatment .", "label": "", "metadata": {}, "score": "38.18997"}
{"text": "Renal Impairment .Dosage adjustments not necessary in adults with renal impairment , including those on hemodialysis or CAPD .Geriatric Patients .Cautions for Moxifloxacin Hydrochloride .", "label": "", "metadata": {}, "score": "38.19328"}
{"text": "Physicians complied with the recommended 400 mg once - daily dose in a large proportion of patients , confirming the advantages of this simple dosing regimen .", "label": "", "metadata": {}, "score": "38.224472"}
{"text": "Advise patients that skipping doses or not completing the full course of therapy may decrease effectiveness and increase the likelihood that bacteria will develop resistance and will not be treatable with moxifloxacin or other antibacterials in the future .", "label": "", "metadata": {}, "score": "38.302452"}
{"text": "In addition , other possible severe and potentially fatal reactions ( may be hypersensitivity reactions or of unknown etiology ) have been reported , most frequently after multiple doses .", "label": "", "metadata": {}, "score": "38.412014"}
{"text": "Results of previous trials of prophylactic use of antibiotics in COPD conducted prior to 1970 demonstrate inconsistent and small benefits of such therapy .However , these studies were limited by the small numbers of patients included , the use of low doses of narrow - spectrum antibiotics , and by inadequate efficacy assessment [ 17 ] .", "label": "", "metadata": {}, "score": "38.590286"}
{"text": "Some patients with very severe infections are admitted to hospital for antibiotic treatment and some are sent home on oral antibiotics .Many patients have moderate infections and are treated as outpatients with daily intravenous antibiotics for 2 - 5 days .", "label": "", "metadata": {}, "score": "38.6707"}
{"text": "The use of inhaled steroid and long - acting bronchodilators , both anticholinergic and beta - agonists , does result in a reduction in exacerbations .", "label": "", "metadata": {}, "score": "38.704407"}
{"text": "Moxifloxacin was prescribed according to the medical judgment of the investigator and in accordance with the guidelines from the European Medicines Agency , the US Food and Drug Administration , and local regulations ( e.g. Avelox \u00ae ( moxifloxacin hydrochloride ) US prescribing information [ 30 ] ) .", "label": "", "metadata": {}, "score": "38.81444"}
{"text": "Kreis SR , Herrera N , Golzar N : A comparison of moxifloxacin and azithromycin in the treatment of acute exacerbations of chronic bronchitis .J Clin Outcomes Manage 2000 , 7 ( 12 ) : 33 - 37 .", "label": "", "metadata": {}, "score": "38.880318"}
{"text": "Concentrations of sulfate and glucuronide conjugates are increased in patients with mild or moderate hepatic impairment ( Child - Pugh class A or B ) ; clinical importance not determined . 1 Plasma concentrations of moxifloxacin and its metabolites in patients with severe hepatic impairment ( Child - Pugh class C ) are similar to those reported in patients with mild or moderate hepatic impairment .", "label": "", "metadata": {}, "score": "38.920494"}
{"text": "Alternative Parenteral Regimen .Ampicillin / sulbactam 3 g IV Q6H + doxycycline 100 mg PO BID .Women who are started on oral antibiotics but do not respond within 72 hours should be reevaluated to confirm the diagnosis of PID and should be administered parenteral therapy on either an outpatient or inpatient basis .", "label": "", "metadata": {}, "score": "38.968422"}
{"text": "J Antimicrob Chemother 1999 , 44 ( 6 ) : 835 - 838 .PubMed View Article .Krasemann C , Meyer J , Springsklee M : Moxifloxacin ( MFX ) in acute exacerbations of chronic bronchitis ( AECB ) : a bacteriological and clinical meta - analysis [ abstract ] .", "label": "", "metadata": {}, "score": "38.968513"}
{"text": "The relatively small number of patients who are intolerant of both TMP / SMX and dapsone should be prophylaxed with either aerosolized pentamidine or atovaquone suspension .", "label": "", "metadata": {}, "score": "39.00307"}
{"text": "[ PubMed 16243476 ] .Giordano P , Song J , Pertel P et al .Sequential intravenous / oral moxifloxacin versus intravenous piperacillin - tazobactam followed by oral amoxicillin - clavulanate for the treatment of complicated skin and skin structure infections .", "label": "", "metadata": {}, "score": "39.20108"}
{"text": "All these patients showed improvement of kidney function with the use of proper antibiotics and resolution of SBP .In conclusion , our study suggests that use of cefotaxime as the first line of treatment is considered valid , since a switch to another antibiotic was necessary only in 19 % of our cases and we suggest meropenem as an effective alternative in resistant cases .", "label": "", "metadata": {}, "score": "39.29686"}
{"text": "Hospitalizations and mortality .In the ITT population there were more patients hospitalized in both groups ( moxifloxacin : 131/569 , 23.0 % ; placebo : 136/580 , 23.4 % ) , but this did not differ significantly between treatments .", "label": "", "metadata": {}, "score": "39.34037"}
{"text": "Alternative Therapies : .TMP ( 5 mg / kg q 8 hours ) plus dapsone ( 100 mg daily ) .Clindamycin ( 600 mg IV / po q 8 hours ) plus primaquine ( 30 mg daily ) .", "label": "", "metadata": {}, "score": "39.37227"}
{"text": "This research supports the use of guanfacine for the treatment of ADHD .In pivotal clinical trials , safety data showed that adverse events reported by participants using INTUNIV were generally mild to moderate in severity , with the most common side effects being sedative in nature .", "label": "", "metadata": {}, "score": "39.40124"}
{"text": "Antimicrobial regimens must be broadly effective against likely pathogens ( see below ) .HIV - infected women appear to respond as well to standard antibiotic regimens as do HIV - uninfected women .", "label": "", "metadata": {}, "score": "39.74594"}
{"text": "There was a transient increase in MIC of one strain of S. pneumoniae and three isolates of S. aureus .However , these isolates did not persist or cause exacerbations , and resistance emergence was not seen among patients in either moxifloxacin or placebo arms .", "label": "", "metadata": {}, "score": "39.75791"}
{"text": "Exacerbations were classified into Anthonisen types I , II , or III [ 13 ] .Exclusion criteria were limited to contraindications to the use of moxifloxacin , as described in the locally available Summary of Product Characteristics .", "label": "", "metadata": {}, "score": "39.803738"}
{"text": "Maximally suppressive antiretroviral therapy has revolutionized the treatment of HIV disease .Patients who respond well to the potent multidrug regimens that are now standard therapy for individuals with advanced HIV infection not only achieve clinical stability , they seem to experience some degree of immune reconstitution .", "label": "", "metadata": {}, "score": "39.824444"}
{"text": "Meningitis and CNS Infections .Safety and efficacy not established for CNS infections .63 Limited data from animal studies indicate moxifloxacin has been effective for treatment of experimental meningitis caused by S. pneumoniae or E. coli .", "label": "", "metadata": {}, "score": "40.098335"}
{"text": "Alternative beta - lactams : cefpodoxime or cefuroxime .A fluoroquinolone a ( AII ) , especially for patients with penicillin allergies .Levofloxacin a 750 mg PO once daily ( AII ) , or .", "label": "", "metadata": {}, "score": "40.175247"}
{"text": "Therefore , the PULSE study was conducted to determine whether intermittent pulsed therapy with the respiratory fluoroquinolone , moxifloxacin , was more efficacious than placebo in the reduction of exacerbations of COPD .", "label": "", "metadata": {}, "score": "40.39895"}
{"text": "View Article .Miravitlles M , Murio C , Guerrero T , Gisbert R , DAFNE Study Group : Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD .", "label": "", "metadata": {}, "score": "40.450886"}
{"text": "Respir Res 2010 , 11 : 10 .PubMed View Article .Ball P , Stahlmann R , Kubin R , Choudhri S , Owens R : Safety profile of oral and intravenous moxifloxacin : cumulative data from clinical trials and postmarketing studies .", "label": "", "metadata": {}, "score": "40.588345"}
{"text": "A meta - analysis of clinical trial and post - marketing surveillance data for moxifloxacin identified nausea , dizziness , and diarrhea as the most frequent adverse events , which occurred at a rate similar to comparator medications [ 35 ] .", "label": "", "metadata": {}, "score": "40.6015"}
{"text": "20 cc ( or 1 double - strength tablet ) po daily or three times a week .More recently , Community Programs for Clinical Research on AIDS Trial 006 found that initiating PCP prophylaxis with thrice- weekly doses -- and then escalating to daily TMP / SMX after the first month of treatment -- reduces the hypersensitivity reactions that commonly occur during the first month of prophylaxis .", "label": "", "metadata": {}, "score": "40.62853"}
{"text": "As ACTG 268 clearly demonstrated , the gradual initiation of TMP / SMX prophylaxis improves its tolerability .In that trial , patients started on the full dose of TMP - SMX were 2.3 times more likely to discontinue therapy than those who received the ramped dose outlined in Table 2 .", "label": "", "metadata": {}, "score": "40.842197"}
{"text": "Alternative Therapy : .An IV antipneumococcal , antipseudomonal beta - lactam + an IV aminoglycoside + IV azithromycin ( BIII ) , or .An IV antipneumococcal , antipseudomonal beta - lactam + an IV aminoglycoside + an IV antipneumococcal fluoroquinolone ( moxifloxacin [ 400 mg / day ] or levofloxacin [ 750 mg / day ] ) ( BIII ) .", "label": "", "metadata": {}, "score": "40.8887"}
{"text": "Advise patients with diabetes mellitus receiving an oral antidiabetic agent or insulin that moxifloxacin may cause alterations in blood glucose concentrations ( hypoglycemia or hyperglycemia ) .", "label": "", "metadata": {}, "score": "41.006325"}
{"text": "Empiric Therapy for Non - ICU Hospitalized Patients Preferred Therapy : .An IV beta - lactam + a macrolide ( azithromycin or clarithromycin ) ( AII ) , or .", "label": "", "metadata": {}, "score": "41.023388"}
{"text": "Abstract P203 .Miravitlles M : Moxifloxacin in respiratory tract infections .Expert Opin Pharmacother 2005 , 6 ( 2 ) : 283 - 293 .", "label": "", "metadata": {}, "score": "41.18524"}
{"text": "PubMed View Article .Simoens S , Decramer M : A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin .Expert Opin Pharmacother 2008 , 9 ( 10 ) : 1735 - 1744 .", "label": "", "metadata": {}, "score": "41.29252"}
{"text": "Using these criteria , the GOLD guidelines recommend amoxicillin / clavulanate or fluoroquinolones in patients with moderate to severe exacerbations .Moxifloxacin is a fourth - generation fluoroquinolone with a broad spectrum of activity relevant to the microorganisms isolated in AECB , including Gram - positive and Gram - negative bacteria , atypical pathogens , and anaerobic bacteria , as well as species resistant to aminoglycosides , tetracyclines , and macrolide antibiotics .", "label": "", "metadata": {}, "score": "41.302067"}
{"text": "PubMed View Article .Van Bambeke F , Tulkens PM : Safety profile of the respiratory fluoroquinolone moxifloxacin : comparison with other fluoroquinolones and other antibacterial classes .", "label": "", "metadata": {}, "score": "41.32231"}
{"text": "Dosage adjustments not necessary in adults with mild , moderate , or severe hepatic impairment ( Child - Pugh class A , B , or C ) .", "label": "", "metadata": {}, "score": "41.37242"}
{"text": "Other studies recommended meropenem use , not only in severe cases but also when ESBL producing E. coli is seen in the cultures and points to a relation between quinolone resistance and ESBL production [ 7 , 24 ] .", "label": "", "metadata": {}, "score": "41.37331"}
{"text": "The clinical study focused on the effect of cefotaxime as the empiric first line therapy for spontaneous bacterial peritonitis and effectiveness of meropenem and levofloxacin as alternatives in case of cefotaxime resistance .", "label": "", "metadata": {}, "score": "41.434967"}
{"text": "Moxifloxacin Hydrochloride .Warning(s ) .Systemic fluoroquinolones , including moxifloxacin , are associated with an increased risk of tendinitis and tendon rupture in all age groups .", "label": "", "metadata": {}, "score": "41.473236"}
{"text": "Intermittent treatment with either moxifloxacin or placebo did not cause sustained MIC increases .For S. aureus , one to three moxifloxacin - resistant isolates were detected at baseline and at different points in the study ; these isolates were not associated with exacerbations and did not persist .", "label": "", "metadata": {}, "score": "41.701664"}
{"text": "This advice applies to all patients , even those who have experienced a significant degree of immune reconstitution as a result of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "41.724514"}
{"text": "Available at .Rimland D , Navin TR , Lennox JL , et al .Prospective study of etiologic agents of community - acquired pneumonia in patients with HIV infection .", "label": "", "metadata": {}, "score": "41.81097"}
{"text": "Antimicrob Agents Chemother .[ IDIS 411422 ] [ PubMed 9687407 ] .Man I , Murphy J , Ferguson J. Fluoroquinlone phototoxicity : a comparison of moxifloxacin and lomefloxacin in normal volunteers .", "label": "", "metadata": {}, "score": "41.83876"}
{"text": "If risk factors for Pseudomonas infection are present , an antipneumococcal , antipseudomonal beta - lactam plus either ciprofloxacin or levofloxacin ( 750-mg dose ) should be used ( BIII ) .", "label": "", "metadata": {}, "score": "41.873978"}
{"text": "Since then , cefotaxime has become the empiric antibiotic of choice for the treatment of SBP .Mortality rates reduced from 90 % when it was first described to around 20%-40 % [ 2 ] .", "label": "", "metadata": {}, "score": "41.896225"}
{"text": "Einarson A , Phillips E , Mawji F , et al .A prospective controlled multicentre study of clarithromycin in pregnancy .American journal of perinatology .", "label": "", "metadata": {}, "score": "41.977253"}
{"text": "Alternative Therapies : .TMP / SMX ( 1 double - strength tablet po three times a week ) .Dapsone ( 50 mg po b.i.d . or 100 mg po daily ) .", "label": "", "metadata": {}, "score": "42.084713"}
{"text": "Adverse events .The overall incidence of adverse events was similar in the moxifloxacin- ( 82.1 % ) and placebo - treated ( 85.0 % ) ITT / safety populations ( Table 1 ) .", "label": "", "metadata": {}, "score": "42.089348"}
{"text": "Similarly , clarithromycin administered daily and azithromycin administered weekly are the drugs of choice for Mycobacterium avium complex ( MAC ) prophylaxis and may be effective in preventing bacterial respiratory infections .", "label": "", "metadata": {}, "score": "42.123825"}
{"text": "Other factors that may independently increase risk of tendon rupture include strenuous physical activity , renal failure , and previous tendon disorders such as rheumatoid arthritis . 1 128 129 Tendinitis and tendon rupture have been reported in patients receiving fluoroquinolones who did not have any of these risk factors .", "label": "", "metadata": {}, "score": "42.12693"}
{"text": "An IV fluoroquinolone a ( AII ) , especially for patients with penicillin allergies .Levofloxacin a 750 mg IV once daily ( AII ) , or .", "label": "", "metadata": {}, "score": "42.14636"}
{"text": "Empiric Antibiotic Therapy by Treatment Setting and Severity of Diseases .Outpatient Treatment .HIV - infected individuals who are being treated as outpatients should receive an oral beta - lactam plus an oral macrolide ( AII ) or an oral respiratory fluoroquinolone ( AII ) .", "label": "", "metadata": {}, "score": "42.176483"}
{"text": "Recommended Parenteral Regimens .Cefotetan 2 g IV Q12H + doxycycline 100 mg PO BID .Cefoxitin 2 g IV Q6H + doxycycline 100 mg PO BID .", "label": "", "metadata": {}, "score": "42.204926"}
{"text": "Nongonococcal Urethritis .319 CDC recommends azithromycin or doxycycline ; 319 alternatives are erythromycin , levofloxacin , or ofloxacin .319 For persistent or recurrent NGU in men compliant with previous treatment who have not been reexposed to an untreated sexual partner(s ) , CDC recommends that those initially treated with azithromycin be retreated with moxifloxacin .", "label": "", "metadata": {}, "score": "42.233604"}
{"text": "Based on PMNL count , we identified the failure of the initial therapy on time .Meropenem use was successful in 100 % of resistant cases .", "label": "", "metadata": {}, "score": "42.26854"}
{"text": "To reduce the risk of such bacterial infections , clinicians can consider taking steps to reverse neutropenia , either by stopping myelosuppressive drugs ( CIII ) or by administering granulocyte - colony stimulating factor ( CIII ) , although these interventions have not been demonstrated to be effective in HIV - infected persons .", "label": "", "metadata": {}, "score": "42.48929"}
{"text": "All patients were inpatients and underwent diagnostic abdominal paracentesis with a differential leucocyte count , microbiological culture , and biochemical analysis at admission .Cefotaxime sodium 2 g/12 h ( iv ) was used as the initial empirical therapy because it is supported by the current guidelines as the first line of therapy for SBP [ 2 ] .", "label": "", "metadata": {}, "score": "42.54046"}
{"text": "In the United States and elsewhere GC commonly is resistant to fluoroquinolone ; thus , this class of antibiotics is no longer recommended for treatment of PID .", "label": "", "metadata": {}, "score": "42.56655"}
{"text": "We speculate that such a dosing regimen was related to the lack of resistance emergence seen in this study although longer periods of observation are needed to confirm this .", "label": "", "metadata": {}, "score": "42.665756"}
{"text": "This means that most cefotaxime resistance cases were associated with advanced liver disease .Fever and abdominal pain were the most frequent manifestations and were reported in 82.7 % and 94.7 % of patients in group I and in 80.2 % and 84.2 % of patients in group II , respectively .", "label": "", "metadata": {}, "score": "42.70871"}
{"text": "Empiric Outpatient Therapy ( Oral ) Preferred Therapy : .An oral beta - lactam + a macrolide ( azithromycin or clarithromycin ) ( AII ) , or .", "label": "", "metadata": {}, "score": "42.8355"}
{"text": "However , such patients should wait at least 1 year after their most recent dose of PPV23 before receiving a single dose of PCV13 ( BIII ) .", "label": "", "metadata": {}, "score": "43.03244"}
{"text": "All patients of group II , in spite of starting treatment of HE , showed no major improvement with cefotaxime , but improvement of consciousness level occurred after the resolution of SBP by the alternative antibiotic therapy .", "label": "", "metadata": {}, "score": "43.05635"}
{"text": "Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis .World J Gastroenterol 2013 ; 19(8 ) : 1271 - 1277 .This article is an open - access article which was selected by an in - house editor and fully peer - reviewed by external reviewers .", "label": "", "metadata": {}, "score": "43.05764"}
{"text": "Advise patients that moxifloxacin may worsen myasthenia gravis symptoms ; importance of immediately contacting clinician if any worsening muscle weakness or breathing problems occur .Advise patients that seizures have been reported ; importance of informing clinician about any history of seizures or current use of NSAIAs before taking moxifloxacin .", "label": "", "metadata": {}, "score": "43.097336"}
{"text": "[ PubMed 15699079 ] .Anzueto A , Niederman MS , Pearle J et al .Community - acquired pneumonia recovery in the elderly ( CAPRIE ) : efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy .", "label": "", "metadata": {}, "score": "43.12753"}
{"text": "Prolonged QT interval leading to ventricular arrhythmias , including torsades de pointes , reported with some fluoroquinolones , including moxifloxacin .Do not exceed usual recommended dosage or IV infusion rate since this may increase risk of prolonged QT interval .", "label": "", "metadata": {}, "score": "43.131065"}
{"text": "Study staff and patients ' regular physicians were instructed to treat exacerbations during the study period with non - fluoroquinolone antibiotics with or without a short course of oral steroids .", "label": "", "metadata": {}, "score": "43.14333"}
{"text": "Rodriquez - Cerrato V , McCoig CC , Saavedra J et al .Garenoxacin ( BMS-284756 ) and moxifloxacin in experimental meningitis caused by vancomycin - tolerant pneumococci .", "label": "", "metadata": {}, "score": "43.18698"}
{"text": "Replace the beta - lactam with aztreonam ( BIII ) .Empiric Therapy for Patients at Risk of Staphylococcus aureus Pneumonia : .Vancomycin IV or linezolid ( IV or PO ) should be added to the baseline regimen ( BIII ) .", "label": "", "metadata": {}, "score": "43.27838"}
{"text": "If parenteral cephalosporin therapy is not feasible , consult with an expert .Limited evidence supports the use of amoxicillin / clavulanic acid with doxycycline , and azithromycin with or without metronidazole or ceftriaxone .", "label": "", "metadata": {}, "score": "43.34012"}
{"text": "Administration .Administer orally or by slow IV infusion . 1 Do not give IM , sub - Q , intrathecally , or intraperitoneally .IV route indicated in patients who do not tolerate or are unable to take the drug orally and in other patients when IV route offers a clinical advantage .", "label": "", "metadata": {}, "score": "43.388344"}
{"text": "Eradication of ascitic fluid infection is the goal of antibiotic therapy .This study confirmed the validity of cefotaxime as an empiric first line therapy for spontaneous bacterial peritonitis and identified meropenem as an effective alternative in cases of cefotaxime resistance .", "label": "", "metadata": {}, "score": "43.45914"}
{"text": "Methods .Study design .The observational period for each patient commenced at the initiation of treatment with moxifloxacin ( Avelox \u00ae ) for AECB and was continued until an improvement or relief of symptoms at follow - up visit or premature discontinuation .", "label": "", "metadata": {}, "score": "43.6124"}
{"text": "Atovaquone suspension ( 1500 mg po daily ) .The patients most likely to experience a breakthrough infection while on PCP prophylaxis are those with CD4 counts below 50 cells / mm 3 , but nonadherence and previous treatment with regimens other than TMP / SMX are also predictive of prophylaxis failure .", "label": "", "metadata": {}, "score": "43.625916"}
{"text": "Epub ahead of print .Miravitlles M , Llor C , Molina J , Naberan K , Cots JM , Ros F : Antibiotic treatment of exacerbations of COPD in general practice : long - term impact on health - related quality of life .", "label": "", "metadata": {}, "score": "43.64817"}
{"text": "Follow - Up .Patients should show significant clinical improvement within 3 days of initiation of therapy ( e.g. , improvement in fever , abdominal tenderness , and uterine , adnexal , and cervical motion tenderness ) .", "label": "", "metadata": {}, "score": "43.75672"}
{"text": "1 If same IV line or a Y - type line used for sequential infusion of other drugs or if piggyback method of administration used , flush tubing before and after infusion of moxifloxacin using IV solution compatible with both moxifloxacin and the other drug(s ) .", "label": "", "metadata": {}, "score": "43.763893"}
{"text": "a Respiratory fluoroquinolones such as levofloxacin or moxifloxacin are also active against Mycobacterium tuberculosis .In patients with undiagnosed TB , fluoroquinolones may alter response to therapy , delay TB diagnosis , and increase the risk of drug resistance .", "label": "", "metadata": {}, "score": "43.790035"}
{"text": "PubMed View Article .Miravitlles M , Zalacain R , Murio C , Ferrer M , Alvarez - Sala JL , Masa JF , Verea H , Ros F , Vidal R : Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two - year study .", "label": "", "metadata": {}, "score": "43.818855"}
{"text": "Aug 15 2004;170(4):440 - 444 .Zolopa A , Andersen J , Powderly W , et al .Early antiretroviral therapy reduces AIDS progression / death in individuals with acute opportunistic infections : a multicenter randomized strategy trial .", "label": "", "metadata": {}, "score": "43.991604"}
{"text": "Physician 's assessments of efficacy of moxifloxacin ( efficacy population ) .Approximately 99 % of both physicians and patients stated that they were ' very satisfied ' or ' satisfied ' with the therapeutic effect of moxifloxacin .", "label": "", "metadata": {}, "score": "44.088604"}
{"text": "Because of the activity of fluoroquinolones against M. tuberculosis and the dangers of monotherapy in those with TB , as previously discussed , fluoroquinolones should be used with caution in patients in whom TB is suspected but who are not being treated with concurrent standard four - drug TB therapy .", "label": "", "metadata": {}, "score": "44.179115"}
{"text": "PubMed View Article .Wilson R , Anzueto A , Miravitlles M , Arvis P , Alder J , Haverstock D , Trajanovic M , Sethi S : Moxifloxacin vs amoxicillin / clavulanic acid in outpatient AECOPD : MAESTRAL results .", "label": "", "metadata": {}, "score": "44.274708"}
{"text": "Risk of photosensitivity / phototoxicity reactions following exposure to sun or UV light while receiving fluoroquinolones .1 Importance of avoiding or minimizing exposure to sunlight or artificial UV light ( e.g. , tanning beds , UVA / UVB treatment ) and using protective measures ( e.g. , wearing loose - fitting clothes , sunscreen ) if outdoors during moxifloxacin therapy .", "label": "", "metadata": {}, "score": "44.278492"}
{"text": "Once again , TMP / SMX is the agent of choice .Although concerns about the teratogenicity of this agent are purely theoretical , clinicians may wish to offer pregnant patients aerosolized pentamidine , rather than TMP - SMX , during the first trimester .", "label": "", "metadata": {}, "score": "44.308777"}
{"text": "GI Infections .412 CDC , NIH , and IDSA recommend ciprofloxacin as drug of choice ; other fluoroquinolones ( levofloxacin , moxifloxacin ) also may be effective .", "label": "", "metadata": {}, "score": "44.32646"}
{"text": "[ PubMed 20034345 ] .Goldstein EJC , Citron DM , Warren YA et al .In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra - abdominal infections .", "label": "", "metadata": {}, "score": "44.367188"}
{"text": "Discontinue moxifloxacin if photosensitivity or phototoxicity ( sunburn - like reaction , skin eruption ) occurs .Other Warnings / Precautions .CNS Effects .CNS effects , including nervousness , agitation , insomnia , anxiety , nightmares , or paranoia , reported with fluoroquinolones , including moxifloxacin .", "label": "", "metadata": {}, "score": "44.489365"}
{"text": "View Article PubMed .Miravitlles M , Marin A , Monso E , Vil\u00e0 S , de la Roza C , Herv\u00e1s R , Esquinas C , Garc\u00eda M , Millares L , Morera J , Torres A : Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD .", "label": "", "metadata": {}, "score": "44.522324"}
{"text": "Efficacy and safety outcomes were analyzed by descriptive statistics .As appropriate for non - interventional studies , statistical tests were not performed .The safety population included all patients who took at least one dose of study medication and provided information on adverse events .", "label": "", "metadata": {}, "score": "44.563057"}
{"text": "[ PubMed 14691652 ] .Pfister K , Mazur D , Vormann J et al .Diminished ciprofloxacin - induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats .", "label": "", "metadata": {}, "score": "44.64308"}
{"text": "Advice to Patients .Advise patients that antibacterials ( including moxifloxacin ) should only be used to treat bacterial infections and not used to treat viral infections ( e.g. , the common cold ) .", "label": "", "metadata": {}, "score": "44.717873"}
{"text": "In one study , the use of dual therapy ( usually with a beta - lactam plus a macrolide ) was associated with reduced mortality in patients with bacteremic pneumococcal pneumonia , including those admitted to the intensive care unit .", "label": "", "metadata": {}, "score": "44.726814"}
{"text": "The use of adjunctive corticosteroids for the treatment of PCP does not increase mortality or the risk of common HIV - associated complications .Although the majority of individuals who develop PCP are unaware of their HIV status at the time of diagnosis , approximately 15 % of PCP cases occur in patients whose serostatus is known but who do not meet the standard criteria for prophylaxis .", "label": "", "metadata": {}, "score": "44.77578"}
{"text": "For the monitored pathogens Staphylococcus spp . , E. coli , Enterococcus spp . , Enterobacter spp . , K. pneumoniae , and P. aeruginosa isolated from the rectal swabs , no consistent major change in the median moxifloxacin MIC was detected in either treatment arm .", "label": "", "metadata": {}, "score": "44.816956"}
{"text": "[ PubMed 16319813 ] .Stass H , Kubitza D. Effects of iron supplements on the oral bioavailability of moxifloxacin , a novel 8-methoxyfluroquinolone , in humans .", "label": "", "metadata": {}, "score": "44.85457"}
{"text": "DOSAGE IN PAEDIATRICS : .IV : . 10mg / kg daily .PO : . 10mg / kg daily Note : see WARNINGS .", "label": "", "metadata": {}, "score": "44.864662"}
{"text": "Warnings / Precautions .Warnings .Tendinopathy and Tendon Rupture .Systemic fluoroquinolones , including moxifloxacin , are associated with increased risk of tendinitis and tendon rupture in all age groups .", "label": "", "metadata": {}, "score": "44.884136"}
{"text": "Drugs That Prolong QT Interval .Potential pharmacologic interaction ( additive effect on QT interval prolongation ) . 1 Avoid use in patients receiving class IA ( e.g. , quinidine , procainamide ) or class III ( e.g. , amiodarone , sotalol ) antiarrhythmic agents . 1 Use with caution in patients receiving drugs that prolong QT interval ( e.g. , cisapride [ commercially available under a limited - access protocol only ] , erythromycin , antipsychotic agents , tricyclic antidepressants ) . 1 ( See Prolongation of QT Interval under Cautions . )", "label": "", "metadata": {}, "score": "44.91817"}
{"text": "[ PubMed 16377674 ] .Kam KM , Yip CW , Cheung TL et al .Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug - resistant Mycobacterium tuberculosis : correlation with ofloxacin susceptibility .", "label": "", "metadata": {}, "score": "45.007553"}
{"text": "Excipients in commercially available drug preparations may have clinically important effects in some individuals ; consult specific product labeling for details .Stass H , Dalhoff A , Kubitza D et al .", "label": "", "metadata": {}, "score": "45.046284"}
{"text": "Fluoroquinolones , including moxifloxacin , may exacerbate muscle weakness in patients with myasthenia gravis . 1 Avoid in patients with known history of myasthenia gravis .", "label": "", "metadata": {}, "score": "45.082222"}
{"text": "Alternative Therapy : .A beta - lactam ( AII ) + doxycycline ( CIII ) .Duration of Therapy : .For most patients : 7 - 10 days ; a minimum of 5 days .", "label": "", "metadata": {}, "score": "45.092308"}
{"text": "PubMed .Burkhardt O , Welte T : 10 years ' experience with the pneumococcal quinolone moxifloxacin .Expert Rev Anti Infect Ther 2009 , 7 ( 6 ) : 645 - 668 .", "label": "", "metadata": {}, "score": "45.10479"}
{"text": "[PubMed ] [ DOI ] .Bernard B , Grang\u00e9 JD , Khac EN , Amiot X , Opolon P , Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding : a meta - analysis .", "label": "", "metadata": {}, "score": "45.12899"}
{"text": "Despite the presence of this mutation , these patients respond to therapy with TMP / SMX , and the role of resistance in breakthrough PCP is unknown .", "label": "", "metadata": {}, "score": "45.18078"}
{"text": "Ascitic fluid culture was positive in 32 % of cases .Cefotaxime failed in 19 % of patients ; of these patients , 11 ( 100 % ) responded to meropenem and 6 ( 75 % ) responded to levofloxacin .", "label": "", "metadata": {}, "score": "45.293884"}
{"text": "Note that patients taking ritonavir capsules may experience symptoms caused by the small amount of alcohol in the capsules ; advise patients to contact the clinic if nausea and vomiting occur .", "label": "", "metadata": {}, "score": "45.306076"}
{"text": "Meropenem is an ultra - broad spectrum injectable antibiotic used to treat a variety of infections .It is a beta lactam antibiotic and belongs to the subgroup of carbapenems ; Levofloxacin is a synthetic chemotheraputic antibiotic which belongs to fluoroquinolone drug class and is used to treat severe or life - threatening bacterial infections or bacterial infections that have failed to respond to other antibiotic classes .", "label": "", "metadata": {}, "score": "45.352165"}
{"text": "There are three main limitations of the present study .This ' placebo ' effect of reduced exacerbations has been observed in other clinical trials and is probably related to closer monitoring and better compliance with maintenance COPD treatments [ 26 ] .", "label": "", "metadata": {}, "score": "45.359333"}
{"text": "Treat empirically for both chlamydia and gonorrhea .If the GC or CT test results are positive , rescreening for GC and CT 3 months after therapy is recommended .", "label": "", "metadata": {}, "score": "45.50015"}
{"text": "Cefotaxime as a standard treatment of SBP has been tried for many years with many reports of evolving resistance to cefotaxime and other third - generation cephalosporins in SBP [ 2 , 5 ] .", "label": "", "metadata": {}, "score": "45.679832"}
{"text": "Use in patients with known or suspected CNS disorders ( e.g. , severe cerebral arteriosclerosis , epilepsy ) or other risk factors that predispose to seizures or lower seizure threshold only if potential benefits of the drug outweigh risks .", "label": "", "metadata": {}, "score": "45.700665"}
{"text": "Other parenteral third - generation cephalosporin ( e.g. , ceftizoxime or cefotaxime ) + doxycycline 100 mg PO BID for 14 days , with or without metronidazole 500 mg PO BID for 14 days .", "label": "", "metadata": {}, "score": "45.70683"}
{"text": "PubMed ] [ DOI ] .Ta\u015fkiran B , Colako\u011flu O , S\u00f6zmen B , Unsal B , Aslan SL , Buyra\u00e7 Z. Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "45.761425"}
{"text": "1 IDSA recommends treatment duration of 4 - 7 days ; 39 longer duration not associated with improved outcome and not recommended unless adequate source control is difficult to achieve .", "label": "", "metadata": {}, "score": "45.84302"}
{"text": "View Article PubMed .Szafranski W , Cukier A , Ramirez A , Menga G , Sansores R , Nahabedian S , Peterson S , Olsson H : Efficacy and safety of budesonide / formoterol in the management of chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "45.911137"}
{"text": "Evidence continues to accumulate that maximally suppressive antiretroviral therapy has a significant impact on AIDS- related morbidity .There have been multiple anecdotal reports that such therapy has a positive therapeutic impact on previously untreatable OIs like progressive multifocal leukoencephalopathy , cryptosporidiosis , and microsporidiosis ( see \" Regression of PML in an aggressively treated patient , \" Vol . 3 , No . 2 ) .", "label": "", "metadata": {}, "score": "45.94005"}
{"text": "20 In many studies , daily administration of TMP - SMX for PCP prophylaxis also reduced the frequency of bacterial respiratory infections .2,41,42 This point should be considered when selecting an agent for PCP prophylaxis ; however , indiscriminate use of this drug ( when not indicated for PCP prophylaxis or other specific reasons ) may promote development of TMP - SMX - resistant organisms .", "label": "", "metadata": {}, "score": "45.948418"}
{"text": "Note -Empiric antimicrobial therapy should be initiated promptly for patients presenting with clinical and radiographic evidence consistent with bacterial pneumonia .The recommendations listed below are suggested empiric therapy .", "label": "", "metadata": {}, "score": "45.967453"}
{"text": "Preferred beta - lactams are ceftriaxone , cefotaxime , or ampicillin - sulbactam .In patients who are allergic to penicillin , aztreonam plus an IV respiratory fluoroquinolone ( moxifloxacin or levofloxacin [ 750 mg / day ] ) should be used ( BIII ) .", "label": "", "metadata": {}, "score": "45.98964"}
{"text": "Use caution in geriatric adults , especially those receiving concomitant corticosteroids .Risk of QT interval prolongation may be increased in geriatric patients . 1 ( See Prolongation of QT Interval under Cautions . )", "label": "", "metadata": {}, "score": "46.01684"}
{"text": "C. difficile infection was not reported in any of the patients taking moxifloxacin .A major concern with antibiotic use is the emergence of resistant organisms .", "label": "", "metadata": {}, "score": "46.09208"}
{"text": "When prescribing a fluoroquinolone , consider potential benefits and risks for the individual patient .128 129 Most patients tolerate the drugs , but serious adverse reactions ( e.g. , CNS effects , QT prolongation , C. difficile -associated diarrhea and colitis , damage to liver , kidneys , or bone marrow , alterations in glucose homeostasis ) may occur rarely .", "label": "", "metadata": {}, "score": "46.26399"}
{"text": "[ PubMed 16584301 ] .Shandil RK , Jayaram R , Kaur P et al .Moxifloxacin , ofloxacin , sparfloxacin , and ciprofloxacin against Mycobacterium tuberculosis : evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy .", "label": "", "metadata": {}, "score": "46.272438"}
{"text": "Current optimal therapy for COPD often does not result in an exacerbation - free patient .Increased incidence of pneumonia with inhaled steroids is an adverse effect when these drugs are used to reduce exacerbations [ 22 , 30 , 31 ] .", "label": "", "metadata": {}, "score": "46.325905"}
{"text": "When selecting or modifying anti - infective therapy , use results of culture and in vitro susceptibility testing . 1 In the absence of such data , consider local epidemiology and susceptibility patterns when selecting anti - infectives for empiric therapy .", "label": "", "metadata": {}, "score": "46.414482"}
{"text": "Antacids , Sucralfate , Metal Cations , Multivitamins .Quinolones form chelates with alkaline earth and transition metal cations .Therefore , moxifloxacin should be taken at least 4 hours before or 8 hours after these agents .", "label": "", "metadata": {}, "score": "46.558006"}
{"text": "Cefotaxime as the empiric first line therapy for spontaneous bacterial peritonitis is effective in 81 % of cases .Meropenem is effective in 100 % of cefotaxime - resistant cases , while levofloxacin is effective in 75 % of cefotaxime - resistant cases .", "label": "", "metadata": {}, "score": "46.721035"}
{"text": "Drug Compatibility .Actions and Spectrum .Like other fluoroquinolones , moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV .Spectrum of activity includes gram - positive aerobic bacteria , some gram - negative aerobic bacteria , some anaerobic bacteria , and some other organisms ( e.g. , Chlamydia , Mycoplasma , Mycobacterium ) .", "label": "", "metadata": {}, "score": "46.751797"}
{"text": "[ PubMed 20307191 ] .Fekety R for the American College of Gastroenterology Practice Parameters Committee .Guidelines for the diagnosis and management of Clostridium difficile -associated diarrhea and colitis .", "label": "", "metadata": {}, "score": "46.814163"}
{"text": "Miravitlles M , Anzueto A , Ewig S , Legnani D , Stauch K : Characterisation of exacerbations of chronic bronchitis and COPD in Europe : the GIANT study .", "label": "", "metadata": {}, "score": "46.957497"}
{"text": "Treatment - related adverse events greater than 10 percent included somnolence ( 32 percent ) , headache ( 26 percent ) , fatigue ( 18 percent ) , upper abdominal pain ( 14 percent ) and sedation ( 13 percent ) .", "label": "", "metadata": {}, "score": "46.988697"}
{"text": "The mean ( SD ) duration of moxifloxacin treatment was 6.4 \u00b1 1.9 days ( range : 1.0 - 15.0 days ) in the efficacy population ; 55.2 % of patients were treated for 5 days , 29.1 % for 7 days , and 14.0 % for 10 days .", "label": "", "metadata": {}, "score": "47.053123"}
{"text": "Beta - lactam antibiotics have not been associated with teratogenicity or increased toxicity in pregnancy .Aminoglycosides can be used as needed .A theoretical risk of fetal renal or eighth nerve damage exists with exposure during pregnancy , but this finding has not been documented in humans , except with streptomycin ( 10 % risk ) and kanamycin ( 2 % risk ) .", "label": "", "metadata": {}, "score": "47.078186"}
{"text": "Efficacy assessments of moxifloxacin treatment .An improvement or relief of the symptoms of AECB that were present at baseline was reported in 89.4 % of patients for sputum volume , 97.2 % for fever , 86.0 % for cough , 87.7 % for dyspnea , and 77.2 % for sputum character during moxifloxacin treatment .", "label": "", "metadata": {}, "score": "47.13294"}
{"text": "Empirical treatment with cefotaxime is effective in 81 % of cases ; meropenem is effective in cefotaxime - resistant cases .Citation : Badawy AA , Zaher TI , Sharaf SM , Emara MH , Shaheen NE , Aly TF .", "label": "", "metadata": {}, "score": "47.415916"}
{"text": "Uses for Moxifloxacin Hydrochloride .Respiratory Tract Infections .Treatment of acute bacterial sinusitis caused by susceptible Streptococcus pneumoniae , Haemophilus influenzae , or Moraxella catarrhalis .", "label": "", "metadata": {}, "score": "47.529984"}
{"text": "1 96 98 99 Initiate appropriate supportive therapy ( e.g. , fluid and electrolyte management , protein supplementation ) , appropriate anti - infective therapy directed against C. difficile ( e.g. , metronidazole , vancomycin ) , and surgical evaluation as clinically indicated .", "label": "", "metadata": {}, "score": "47.53664"}
{"text": "Other Microorganisms : Chlamydia pneumoniae , Mycoplasma pneumoniae .CONTRAINDICATIONS : 1 . hypersensitivity to moxifloxacin or any member of the quinolone class of . antimicrobials .", "label": "", "metadata": {}, "score": "47.575134"}
{"text": "Health status .Total scores on the SGRQ improved from baseline for both moxifloxacin and placebo .The SGRQ domain scores of symptoms , activity and impact were also assessed ( see Additional file 6 : Additional results , Table S6 ) .", "label": "", "metadata": {}, "score": "47.597183"}
{"text": "Moxifloxacin is strongly targeted to alveolar tissue [ 18 , 19 ] and demonstrates rapid initial killing and eradication rates for pneumococcal bacteria [ 16 ] .", "label": "", "metadata": {}, "score": "47.70085"}
{"text": "In group II the meropenem subgroup had higher LDH and PMNL count at initiation of the alternative antibiotic therapy ; there was no significant difference in the studied parameters between patients responsive to meropenem and levofloxacin at the end of therapy .", "label": "", "metadata": {}, "score": "47.7429"}
{"text": "PubMed View Article .Llor C , Sierra N , Hernandez S , Moragas A , Hernandez M , Bayona C , Miravitlles M : The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance .", "label": "", "metadata": {}, "score": "47.744408"}
{"text": "2 More recently , the incidence of bacterial pneumonia in HIV - infected individuals has declined .In one study , the incidence of bacterial pneumonia declined from 22.7 episodes per 100 person - years in the era before combination antiretroviral therapy ( ART ) to 9.1 episodes per 100 person - years by 1997 .", "label": "", "metadata": {}, "score": "47.76544"}
{"text": "Increasing rates of pneumococcal resistance suggest that empirical therapy with a macrolide alone can not be routinely recommended ( BIII ) .Patients who are receiving a macrolide for MAC prophylaxis should never receive macrolide monotherapy for empiric treatment of bacterial pneumonia , but macrolides can be used as part of a combination regimen .", "label": "", "metadata": {}, "score": "47.76577"}
{"text": "[PubMed ] [ DOI ] .Ariza X , Castellote J , Lora - Tamayo J , Girbau A , Salord S , Rota R , Ariza J , Xiol X. Risk factors for resistance to ceftriaxone and its impact on mortality in community , healthcare and nosocomial spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "47.80339"}
{"text": "In the placebo group , the median MIC of moxifloxacin against P. aeruginosa isolates increased from 0.5 mg / L at randomization to 2 mg / L by EOT .", "label": "", "metadata": {}, "score": "47.945427"}
{"text": "Advise patients that diarrhea is a common problem caused by anti - infectives and usually ends when the drug is discontinued .1 Importance of contacting a clinician if watery and bloody stools ( with or without stomach cramps and fever ) occur during or as late as 2 months or longer after the last dose .", "label": "", "metadata": {}, "score": "47.9477"}
{"text": "Pharmacoepidemiology and drug safety .Dec 2000;9(7):549 - 556 .Schaefer C , Amoura - Elefant E , Vial T , et al .Pregnancy outcome after prenatal quinolone exposure .", "label": "", "metadata": {}, "score": "48.109413"}
{"text": "Black P , Staykova T , Chako E , Rams FS , Poole P : Prophylactic antibiotic therapy for chronic bronchitis .Cochrane Database Syst Rev 2003 , 1 : CD004105 .", "label": "", "metadata": {}, "score": "48.149063"}
{"text": "671 If a fluoroquinolone is included in treatment regimen ( e.g. , for macrolide - resistant MAC infections ) , moxifloxacin or levofloxacin may be preferred , 412 671 although many strains are resistant in vitro .", "label": "", "metadata": {}, "score": "48.18953"}
{"text": "Patients experienced AECB symptoms for a mean of 7.0 \u00b1 5.0 days before initiation of treatment with moxifloxacin .Table 2 .Impact of current AECB episode on daily life activities and sleep disturbance ( efficacy population ) .", "label": "", "metadata": {}, "score": "48.220074"}
{"text": "There were no statistically significant differences in baseline characteristics between the ITT and PP EOT populations , or between patients randomized to moxifloxacin or placebo .", "label": "", "metadata": {}, "score": "48.26552"}
{"text": "Advise patients that PID can recur , and that they should contact the clinic if symptoms such as pain or fever develop .Patients must not drink beer , wine , or any other alcoholic beverage while taking metronidazole , and for at least 24 - 48 hours after the last dose .", "label": "", "metadata": {}, "score": "48.426323"}
{"text": "Patients in group II had a more severe ascitic inflammatory response than group I and this was demonstrated by the more ascitic LDH and PMNL counts .", "label": "", "metadata": {}, "score": "48.459435"}
{"text": "Immediately discontinue moxifloxacin if symptoms of peripheral neuropathy ( e.g. , pain , burning , tingling , numbness , weakness ) occur or if there are alterations in sensations ( e.g. , light touch , pain , temperature , position sense , vibratory sensation ) .", "label": "", "metadata": {}, "score": "48.502598"}
{"text": "[ PubMed 17210779 ] .Cohen SH , Gerding DN , Johnson S et al .Clinical practice guidelines for Clostridium difficile infection in adults : 2010 update by the Society for Healthcare Epidemiology of America ( SHEA ) and the Infectious Diseases Society of America ( IDSA ) .", "label": "", "metadata": {}, "score": "48.528603"}
{"text": "Endocarditis . 127 AHA and IDSA recommend ceftriaxone or ampicillin - sulbactam as drugs of choice , 127 but a fluoroquinolone ( ciprofloxacin , levofloxacin , moxifloxacin ) may be considered when \u03b2 - lactam anti - infectives can not be used .", "label": "", "metadata": {}, "score": "48.535843"}
{"text": "The size and duration of the study were not adequate for these secondary end points .In the patient population recruited in this study , hospitalization and mortality rates were low , making it difficult to observe a difference between the two treatment groups .", "label": "", "metadata": {}, "score": "48.56314"}
{"text": "The primary efficacy variable was the number of exacerbations recorded after 48 weeks of intermittent pulsed therapy .Odds ratios , adjusted for region and % PFEV 1 , were calculated for the mean rate of exacerbations .", "label": "", "metadata": {}, "score": "48.575104"}
{"text": "Although its safety during the first trimester has not been evaluated , no adverse consequences have been reported among newborns whose mothers were inadvertently vaccinated during pregnancy .", "label": "", "metadata": {}, "score": "48.637234"}
{"text": "Jan 2010;14(1):e22 - 27 .Weinstein MP , Klugman KP , Jones RN .Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae : coping with antimicrobial susceptibility in an era of resistance .", "label": "", "metadata": {}, "score": "48.69614"}
{"text": "Table S2 .Frequency of hospitalization and mortality .Data are shown for moxifloxacin- and placebo - treated patients , for the per - protocol end - of - treatment ( PP EOT ) and intent - to - treat ( ITT ) populations from Week 0 to Week 48 .", "label": "", "metadata": {}, "score": "48.71763"}
{"text": "PubMed View Article .Miravitlles M , Torres A : Antibiotics in exacerbations of COPD : lessons from the past .Eur Respir J 2004 , 24 ( 6 ) : 896 - 897 .", "label": "", "metadata": {}, "score": "48.8148"}
{"text": "PubMed View Article .Doll H , Miravitlles M : Health - related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease : a review of the literature .", "label": "", "metadata": {}, "score": "48.87932"}
{"text": "As all clinicians who treat HIV- infected patients know only too well , adverse reactions to TMP - SMX -- principally severe rash -- are seen in a significant percentage of the individuals treated with this sulfa- based drug .", "label": "", "metadata": {}, "score": "48.89412"}
{"text": "PubMed View Article .Anthonisen NR , Manfreda J , Warren CP , Hershfield ES , Harding GK , Nelson NA : Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "48.895523"}
{"text": "[ IDIS 386628 ] [ PubMed 9149180 ] .American Society of Health - System Pharmacists Commission on Therapeutics .ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile -associated disease .", "label": "", "metadata": {}, "score": "48.938606"}
{"text": "Angeloni et al [ 12 ] revealed positive cultures in 30 % of episodes with predominantly Gram negative bacteria ; in these episodes the percentage of treatment failure of the initial therapy with cefotaxime was 32 % and this result is similar to our findings . aureus ( one patient ) .", "label": "", "metadata": {}, "score": "48.94146"}
{"text": "View Article PubMed .Casaburi R , Mahler DA , Jones PW , Wanner A , San PG , ZuWallack RL , Menjoge SS , Serby CW , Witek T Jr : A long - term evaluation of once - daily inhaled tiotropium in chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "49.041306"}
{"text": "1 683 688 Drugs of choice for such prophylaxis are doxycycline ( or tetracycline ) or a fluoroquinolone ( ciprofloxacin , levofloxacin , moxifloxacin , ofloxacin ) ; co - trimoxazole and chloramphenicol are alternatives .", "label": "", "metadata": {}, "score": "49.070686"}
{"text": "[PubMed ] [ DOI ] .Angeloni S , Leboffe C , Parente A , Venditti M , Giordano A , Merli M , Riggio O. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice .", "label": "", "metadata": {}, "score": "49.116543"}
{"text": "The clinical response to appropriate antimicrobial therapy is similar in HIV - infected patients and individuals who are not HIV infected .54 A clinical response ( i.e. , reduction in fever and improvement in respiratory symptoms , physical findings , and laboratory studies ) typically is observed within 48 to 72 hours after initiation of appropriate antimicrobial therapy .", "label": "", "metadata": {}, "score": "49.178078"}
{"text": "Jun 1 2009;48(11):1596 - 1600 .Baddour LM , Yu VL , Klugman KP , et al .Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia .", "label": "", "metadata": {}, "score": "49.23685"}
{"text": "[ PubMed 16229991 ] .Rodriguez - Cerrato V , McCoig CC , Michelow IC et al .Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis .", "label": "", "metadata": {}, "score": "49.54517"}
{"text": "Hypoglycemia or Hyperglycemia .Alterations in blood glucose concentrations , including hypoglycemia and hyperglycemia , reported with fluoroquinolones , including moxifloxacin .1 Alterations usually have occurred in elderly patients with diabetes mellitus receiving an oral antidiabetic agent ( e.g. , sulfonylurea agent ) or insulin .", "label": "", "metadata": {}, "score": "49.56572"}
{"text": "1 If a hypoglycemic reaction occurs , discontinue moxifloxacin and initiate appropriate therapy immediately .Superinfection / Clostridium difficile - associated Diarrhea and Colitis ( CDAD ) .", "label": "", "metadata": {}, "score": "49.645157"}
{"text": "Oct 1 1999;13(14):1971 - 1975 .Breiman RF , Keller DW , Phelan MA , et al .Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV - infected patients .", "label": "", "metadata": {}, "score": "49.682228"}
{"text": "A minimum of 1600 patients were planned to be included in the study .As 2672 patients were actually included , adverse events occurring at a frequency of 0.125 % ( 1:800 patients ) could be detected with a probability of 95 % .", "label": "", "metadata": {}, "score": "49.733337"}
{"text": "Otherwise , they may be reinfected .Advise patients to avoid sexual contact until the infection has been cured .Provide education about sexual risk reduction .", "label": "", "metadata": {}, "score": "49.75918"}
{"text": "However approximately 10 % of patients with SBP are asymptomatic [ 14 ] ; in our study asymptomatic patients made up 18.5 % of the cefotaxime sensitive group , but all patients in the resistant group had clinical manifestations .", "label": "", "metadata": {}, "score": "49.763046"}
{"text": "Patients .In addition , they had to have chronic bronchitis as defined by the American Thoracic Society [ 20 ] and at least two exacerbations requiring treatment with antibiotics and/or oral steroids in the 12 months prior to enrolment .", "label": "", "metadata": {}, "score": "49.850243"}
{"text": "[ IDIS 442447 ] [ PubMed 10730681 ] .Solomkin JS , Mazuski JE , Bradley JS et al .Diagnosis and management of complicated intra - abdominal infection in adults and children : guidelines by the Surgical Infection Society and the Infectious Diseases Society of America .", "label": "", "metadata": {}, "score": "49.86225"}
{"text": "[ IDIS 438052 ] [ PubMed 10543767 ] .Nightingale CH .Moxifloxacin , a new antibiotic designed to treat community - acquired respiratory tract infections : a review of microbiologic and pharmacokinetic - pharmacodynamic characteristics .", "label": "", "metadata": {}, "score": "49.940907"}
{"text": "Normal saline Glucose and sodium chloride Store at room temperature Do not store below 8 \u00b0 C .PO .Avelox 400 mg tablets .DOSAGE : .", "label": "", "metadata": {}, "score": "49.973267"}
{"text": "[ PubMed 17084757 ] .Johnson JL , Hadad DJ , Boom WH et al .Early and extended early bactericidal activity of levofloxacin , gatifloxacin and moxifloxacin in pulmonary tuberculosis .", "label": "", "metadata": {}, "score": "49.985126"}
{"text": "Other Considerations .Empiric therapy with a macrolide alone is not routinely recommended because of increasing pneumococcal resistance ( BIII ) .Patients receiving a macrolide for MAC prophylaxis should not receive macrolide monotherapy for empiric treatment of bacterial pneumonia .", "label": "", "metadata": {}, "score": "49.992783"}
{"text": "Respiratory fluoroquinolones also are active against M. tuberculosis .Thus , patients with TB who are treated with fluoroquinolone monotherapy may have an initial but misleading response that could delay diagnosis of TB and initiation of appropriate multidrug TB therapy and increase risk of drug - resistant TB and TB transmission .", "label": "", "metadata": {}, "score": "50.056084"}
{"text": "[PubMed ] [ DOI ] .Bert F , Noussair L , Lambert - Zechovsky N , Valla D. Viridans group streptococci : an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites .", "label": "", "metadata": {}, "score": "50.132492"}
{"text": "Clin Infect Dis .2007;44(Suppl 2):S27 - 72 .Available at .Jordano Q , Falco V , Almirante B , et al .Invasive pneumococcal disease in patients infected with HIV : still a threat in the era of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "50.145"}
{"text": "Data are shown for the entire 72 weeks of the study : 48 weeks of intermittent therapy and 24 weeks of follow - up .S , screening visit ; R , randomization visit ; EOT , end - of - treatment visit ; MIC , minimum inhibitory concentration ; numbers in the table are of patients with an isolate at a given time point .", "label": "", "metadata": {}, "score": "50.183178"}
{"text": "Apr 1 2008;46(7):1093 - 1100 .Teshale EH , Hanson D , Flannery B , et al .Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV - infected adults in the United States , 1998 - -2003 .", "label": "", "metadata": {}, "score": "50.216755"}
{"text": "[PubMed ] [ DOI ] .Sort P , Navasa M , Arroyo V , Aldeguer X , Planas R , Ruiz - del - Arbol L , Castells L , Vargas V , Soriano G , Guevara M. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "50.24562"}
{"text": "Often , the differential diagnosis of pneumonia in HIV - infected individuals is broad and a confirmed microbiologic diagnosis allows clinicians to target the specific pathogen and discontinue broad spectrum antibiotic therapy and/or empiric therapy ( such as empiric PCP therapy ) that targets non - bacterial pathogens .", "label": "", "metadata": {}, "score": "50.25438"}
{"text": "However , caution should be used if the IUD remains in place , and close clinical follow - up is recommended .The goals of treatment include the following : .", "label": "", "metadata": {}, "score": "50.26833"}
{"text": "Pediatric Use . 1 Like other quinolones , moxifloxacin causes arthropathy in juvenile animals . 1 ( See Musculoskeletal Effects under Cautions . )Geriatric Use .", "label": "", "metadata": {}, "score": "50.284912"}
{"text": "In this study , the most commonly reported treatment emergent adverse events ( greater than or equal to 10 percent ) were somnolence , headache , sedation , upper abdominal pain , fatigue and irritability .", "label": "", "metadata": {}, "score": "50.297634"}
{"text": "N Engl J Med .Dec 24 1992;327(26):1842 - 1848 .Havlir DV , Dube MP , Sattler FR , et al .Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin , daily rifabutin , or both .", "label": "", "metadata": {}, "score": "50.409565"}
{"text": "Prescribing Limits .Adults .Special Populations .Hepatic Impairment .Dosage adjustments not necessary in adults with mild , moderate , or severe hepatic impairment ( Child - Pugh class A , B , or C ) .", "label": "", "metadata": {}, "score": "50.449375"}
{"text": "[ PubMed 12760860 ] .Mandell LA , Wunderink RG , Anzueto A et al .Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community - acquired pneumonia in adults .", "label": "", "metadata": {}, "score": "50.49536"}
{"text": "AECB , acute exacerbation of chronic bronchitis .In the ITT population the mean ( SD ) rate of exacerbations ( primary definition ) was 0.94 ( 1.24 ) vs 0.88 ( 1.29 ) for placebo and moxifloxacin , respectively .", "label": "", "metadata": {}, "score": "50.505066"}
{"text": "The majority of these cases occurred in the long - term , open label studies .Small to modest changes in blood pressure , pulse rate , and ECG parameters were observed .", "label": "", "metadata": {}, "score": "50.599213"}
{"text": "COMMENTS .Background .Spontaneous bacterial peritonitis is infection of ascitic fluid in cirrhotic patients with high mortality rates .Cefotaxime has become the empiric antibiotic of choice for the treatment since 1985 .", "label": "", "metadata": {}, "score": "50.631058"}
{"text": "Alternative Therapy : .An IV beta - lactam ( AII ) + doxycycline ( CIII ) .IV penicillin may be used for confirmed pneumococcal pneumonia ( BIII ) .", "label": "", "metadata": {}, "score": "50.63241"}
{"text": "In this study , resistance to cefotaxime is associated with more advanced liver disease , because 94.7 % and 5.3 % of cases were Child C and B respectively .", "label": "", "metadata": {}, "score": "50.661274"}
{"text": "Hung CC , Chen MY , Hsieh SM , Hsiao CF , Sheng WH , Chang SC .Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy : a prospective observational study .", "label": "", "metadata": {}, "score": "50.713604"}
{"text": "This chapter will focus on the diagnosis , prevention , and management of bacterial pneumonia in HIV - infected patients .Bacterial pneumonia is a common cause of HIV - associated morbidity and recurrent pneumonia ( 2 or more episodes within a 1-year period ) is an AIDS - defining condition .", "label": "", "metadata": {}, "score": "50.73492"}
{"text": "Preferred macrolides are azithromycin or clarithromycin .Doxycycline is an alternative to the macrolide ( CIII ) .Preferred oral respiratory fluoroquinolones are moxifloxacin or levofloxacin .", "label": "", "metadata": {}, "score": "50.802876"}
{"text": "Treatment was repeated every 8 weeks for a total of 6 courses .After randomization , patients were seen every 8 weeks for clinical evaluation to record any exacerbations and adverse events , and to dispense the medication course .", "label": "", "metadata": {}, "score": "51.132874"}
{"text": "2001 ; 40 ( suppl 1):57 - 62 .[ PubMed 11352443 ] .Lettieri J , Vargas R , Agarwal V et al .Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400 mg in healthy male volunteers .", "label": "", "metadata": {}, "score": "51.18876"}
{"text": "Patients were instructed to continue with study medication in the event of an exacerbation .Outcome measurements .The primary efficacy end point was the frequency of exacerbations during the treatment period , from randomization to the EOT visit at 48 weeks .", "label": "", "metadata": {}, "score": "51.28432"}
{"text": "671 Moxifloxacin may be preferred if a fluoroquinolone is used in conjunction with other antimycobacterial anti - infectives for the treatment of MAC infections , but many strains are resistant in vitro . 671", "label": "", "metadata": {}, "score": "51.36051"}
{"text": "Other Mycobacterial Infections . 671ATS and IDSA recommend a multiple - drug regimen of isoniazid , rifampin , and ethambutol for treatment of pulmonary or disseminated infections caused by M. kansasii .", "label": "", "metadata": {}, "score": "51.37329"}
{"text": "[PubMed ] [ DOI ] .Cormican MG , Runyon BA , Jones RN .In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "51.37672"}
{"text": "Feb 19 2008;148(4):249 - 257 .Lobo LJ , Reed KD , Wunderink RG .Expanded clinical presentation of community - acquired methicillin - resistant Staphylococcus aureus pneumonia .", "label": "", "metadata": {}, "score": "51.430798"}
{"text": "Three additional follow - up visits at 8-weekly intervals were conducted for a total study duration of 72 weeks .Clinical laboratory assessments , including blood chemistry and haematology , were performed pre - treatment , 24 weeks after randomization , and at the end of treatment .", "label": "", "metadata": {}, "score": "51.557907"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT00323219 .Cellulitis Emergencies Soft Tissue Infections Connective Tissue Diseases Disease Attributes Infection Inflammation Pathologic Processes Skin Diseases , Infectious Suppuration Cefazolin Moxifloxacin Norgestimate , ethinyl estradiol drug combination Probenecid Anti - Bacterial Agents .", "label": "", "metadata": {}, "score": "51.611603"}
{"text": "Oct 12 2012;61(40):816 - 819 .French N , Gordon SB , Mwalukomo T , et al .A trial of a 7-valent pneumococcal conjugate vaccine in HIV - infected adults .", "label": "", "metadata": {}, "score": "51.748806"}
{"text": "In clinical trials , INTUNIV demonstrated significant reduction in ADHD symptoms .INTUNIV is not a controlled substance and has no known mechanism for abuse or dependence .", "label": "", "metadata": {}, "score": "51.764454"}
{"text": "Hypersensitivity Reactions Serious and occasionally fatal hypersensitivity ( anaphylactic ) reactions , some following the first dose , have been reported in patients receiving quinolone therapy .", "label": "", "metadata": {}, "score": "51.842743"}
{"text": "292 412 Empiric treatment regimen can be used initially , but in vitro susceptibility testing indicated since resistance is common .292 Fluoroquinolones ( e.g. , ciprofloxacin , levofloxacin , moxifloxacin ) are drugs of choice when susceptibility of the isolate is unknown or ampicillin- or co - trimoxazole - resistant strains are involved .", "label": "", "metadata": {}, "score": "51.95867"}
{"text": "Mar 4 2010;362(9):812 - 822 .Penaranda M , Falco V , Payeras A , et al .Effectiveness of polysaccharide pneumococcal vaccine in HIV - infected patients : a case - control study .", "label": "", "metadata": {}, "score": "51.985416"}
{"text": "PubMed .Ernst P , Gonzalez AV , Brassard P , Suissa S : Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia .", "label": "", "metadata": {}, "score": "52.152138"}
{"text": "Tuberculosis .CDC , ATS , and IDSA state that use of fluoroquinolones can be considered in patients with relapse , treatment failure , or M. tuberculosis resistant to isoniazid and/or rifampin or when first - line drugs can not be tolerated .", "label": "", "metadata": {}, "score": "52.158672"}
{"text": "Indications for hospitalization of patients with PID include the following : .Unsure diagnosis ; surgical emergency can not be excluded .Pregnancy .Patient does not respond clinically ( within 72 hours ) to oral antimicrobial therapy .", "label": "", "metadata": {}, "score": "52.180046"}
{"text": "Wilson R , Jones P , Schaberg T , Arvis P , Duprat - Lomon I , Sagnier PP : Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis .", "label": "", "metadata": {}, "score": "52.209816"}
{"text": "Jul 2010;138(1):130 - 136 .Heffernan RT , Barrett NL , Gallagher KM , et al .Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy , 1995 - 2000 .", "label": "", "metadata": {}, "score": "52.21203"}
{"text": "If you are not finding what you need , try searching similar terms ( i.e. perinatal OR pregnancy ) to broaden your search .Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV - Infected Adults and Adolescents .", "label": "", "metadata": {}, "score": "52.28824"}
{"text": "In patients who have risk factors for S. aureus infection , including community - acquired MRSA , vancomycin or linezolid should be added to the antibiotic regimen ( BIII ) .", "label": "", "metadata": {}, "score": "52.359093"}
{"text": "Bacterial respiratory tract infections should be managed as in women who are not pregnant , with certain exceptions .Clarithromycin is not recommended as the first - line agent among macrolides because of an increased risk of birth defects seen in some animal studies .", "label": "", "metadata": {}, "score": "52.412106"}
{"text": "Jun 1998;42(6):1336 - 1339 .Nahum GG , Uhl K , Kennedy DL .Antibiotic use in pregnancy and lactation : what is and is not known about teratogenic and toxic risks .", "label": "", "metadata": {}, "score": "52.419548"}
{"text": "[PubMed ] [ DOI ] .Riggio O , Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis .World J Gastroenterol .", "label": "", "metadata": {}, "score": "52.480965"}
{"text": "All patients underwent a final diagnostic paracentesis with a differential leucocyte count at the end of therapy .The antibiotic dosage was adjusted to renal function throughout the treatment period .", "label": "", "metadata": {}, "score": "52.49719"}
{"text": "31 Do not use a fluoroquinolone alone for empiric treatment of CAP in patients requiring treatment in an intensive care unit ( ICU ) .For empiric outpatient treatment of CAP in previously healthy adults without risk factors for drug - resistant S. pneumoniae ( DRSP ) , IDSA and ATS recommend monotherapy with a macrolide ( azithromycin , clarithromycin , erythromycin ) or , alternatively , doxycycline .", "label": "", "metadata": {}, "score": "52.512527"}
{"text": "[ PubMed 16377680 ] .Betriu C , Rodriguez AI , Gomez M et al .Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period ( 1997 - 2002 ) .", "label": "", "metadata": {}, "score": "52.53102"}
{"text": "Alternatives are an antipneumococcal , antipseudomonal beta - lactam plus an aminoglycoside and azithromycin ( BIII ) or an antipneumococcal , antipseudomonal beta - lactam plus an aminoglycoside and an antipneumococcal fluoroquinolone ( BIII ) .", "label": "", "metadata": {}, "score": "52.636105"}
{"text": "Importance of informing clinician if medical history includes psychiatric illness .May be associated with hypersensitivity reactions ( including anaphylactic reactions ) , even after a single dose .", "label": "", "metadata": {}, "score": "52.7101"}
{"text": "In the ITT population without purulent / mucopurulent sputum , the reduction in the odds of having an exacerbation with moxifloxacin was also not statistically significant .", "label": "", "metadata": {}, "score": "52.72441"}
{"text": "In the PP EOT population there was 1/351 ( 0.3 % ) death in the moxifloxacin group and 3/387 ( 0.8 % ) deaths in the placebo group ( see Additional file 6 : Additional results , Table S2 ) .", "label": "", "metadata": {}, "score": "52.749687"}
{"text": "Patient Education .Instruct patients to take all of their medications .Advise patients to take medications with food if they feel nauseated , and to contact the clinic promptly if they experience vomiting or are unable to take their medications .", "label": "", "metadata": {}, "score": "52.791573"}
{"text": "The final number was 11 patients in the meropenem subgroup and 8 in the levofloxacin subgroup .All cases with initially positive ascitic fluid culture were re - cultured .", "label": "", "metadata": {}, "score": "52.8591"}
{"text": "1 23 Institute appropriate therapy as indicated ( e.g. , epinephrine , corticosteroids , and maintenance of an adequate airway and oxygen ) .Photosensitivity Reactions .", "label": "", "metadata": {}, "score": "52.91305"}
{"text": "Regarding the laboratory parameters ( Table 2 ) , patients in group II had a greater peripheral blood leucocyte response than group I. .Ascitic fluid culture was positive in only 32 % of cases .", "label": "", "metadata": {}, "score": "53.015488"}
{"text": "In addition , mortality has been shown to increase with frequent , severe exacerbations , particularly if these require hospitalization [ 5 ] .Exacerbations account for between one - third to one - half of the health economic burden of COPD [ 6 , 7 ] .", "label": "", "metadata": {}, "score": "53.017555"}
{"text": "This would explain the drastic reduction we have seen in the incidence of AIDS - related opportunistic infections in patients with late - stage HIV disease .", "label": "", "metadata": {}, "score": "53.050095"}
{"text": "1999 ; 43(Suppl):B77-B82 .[ IDIS 428610 ] [ PubMed 10382879 ] .Bishai W. Current issues on resistance , treatment guidelines , and the appropriate use of fluoroquinolones for respiratory tract infections .", "label": "", "metadata": {}, "score": "53.065308"}
{"text": "1465 - 9921 - 11 - 10-S6.DOC Additional file 6 : Additional results .Figure S1 .Time to first exacerbation in ( a ) the PP EOT population and ( b ) the ITT population .", "label": "", "metadata": {}, "score": "53.085396"}
{"text": "2001 ; 40 ( suppl 1):33 - 8 .[ PubMed 11352440 ] .Hori S , Kizu J , Kawamura M. Effects of anti - inflammatory drugs on convulsant activity of quinolones : a comparative study of drug interactions between quinolones and anti - inflammatory drugs .", "label": "", "metadata": {}, "score": "53.182335"}
{"text": "[ PubMed 17145798 ] .Loo VG , Poirier L , Miller MA et al .A predominantly clonal multi - institutional outbreak of Clostridium difficile -associated diarrhea with high morbidity and mortality .", "label": "", "metadata": {}, "score": "53.259415"}
{"text": "Peripheral Neuropathy .Sensory or sensorimotor axonal polyneuropathy affecting small and/or large axons resulting in paresthesias , hypoesthesias , dysesthesias , and weakness reported with fluoroquinolones , including moxifloxacin .", "label": "", "metadata": {}, "score": "53.269997"}
{"text": "Jun 1 2004;38(11):1623 - 1628 .Hamel MJ , Greene C , Chiller T , et al .Does cotrimoxazole prophylaxis for the prevention of HIV - associated opportunistic infections select for resistant pathogens in Kenyan adults ?", "label": "", "metadata": {}, "score": "53.36383"}
{"text": "May 2010;16(3):201 - 207 .Malinis M , Myers J , Bordon J , et al .Clinical outcomes of HIV - infected patients hospitalized with bacterial community - acquired pneumonia .", "label": "", "metadata": {}, "score": "53.389935"}
{"text": "Laboratory Tests : .No tests in addition to usual ICU tests are indicated .Drug / Laboratory Test Interactions : .None of note .", "label": "", "metadata": {}, "score": "53.427067"}
{"text": "Woodhead M , Blasi F , Ewig S , Garau J , Huchon G , Ieven M , Ortqvist A , Schaberg T , Torres A , van der Heijden G , Read R , Verheij TJ : Guidelines for the management of adult lower respiratory tract infections - full version .", "label": "", "metadata": {}, "score": "53.522842"}
{"text": "The absolute risk reduction for exacerbation was 4.9 % and the NNT was 21 .Subgroup analyses .Predefined efficacy subgroups .The ORs achieved for most of the predefined efficacy subgroups were similar to those for the overall PP and ITT populations ( see Additional file 6 : Additional results , Table S1 ) .", "label": "", "metadata": {}, "score": "53.60737"}
{"text": "2009;4(5):e5575 .Christensen D , Feldman C , Rossi P , al e. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community - acquired pneumonia : results from the CAPO international cohort study .", "label": "", "metadata": {}, "score": "53.66712"}
{"text": "All patients performed an end of treatment ascitic PMNL count .RESULTS : Age , sex , and Child classes showed no significant difference between group I and group II .", "label": "", "metadata": {}, "score": "53.70423"}
{"text": "1465 - 9921 - 11 - 10-S2.DOC Additional file 2 : Pre - specified protocol violations .Protocol violations that resulted in patients being excluded from the per - protocol population .", "label": "", "metadata": {}, "score": "53.712227"}
{"text": "Aug 2006;44(8 Suppl 2):S52 - 60 .Benard A , Mercie P , Alioum A , et al .Bacterial pneumonia among HIV - infected patients : decreased risk after tobacco smoking cessation .", "label": "", "metadata": {}, "score": "53.73427"}
{"text": "There were no significant differences between moxifloxacin and placebo in any pre - specified efficacy subgroup analyses or in hospitalization rates , mortality rates , lung function or changes in St George 's Respiratory Questionnaire ( SGRQ ) total scores .", "label": "", "metadata": {}, "score": "53.771683"}
{"text": "The serious TEAEs were considered to be drug related .All serious TEAEs had resolved by the end of the observational period , following interruption of moxifloxacin treatment in three patients and treatment withdrawal in one patient .", "label": "", "metadata": {}, "score": "53.790775"}
{"text": "Consider CDAD if diarrhea develops and manage accordingly .1 96 98 99 Careful medical history necessary since CDAD may occur as late as 2 months or longer after anti - infective therapy is discontinued .", "label": "", "metadata": {}, "score": "53.844643"}
{"text": "Patients with mucopurulent / purulent sputum .For this subgroup , the absolute risk reduction in exacerbations was 14.4 % and the NNT to prevent one exacerbation is 7 .", "label": "", "metadata": {}, "score": "53.85804"}
{"text": "Instruct patients to use condoms with every sexual contact to prevent reinfection with GC and CT , to prevent other STDs , and to prevent passing HIV to sex partners .", "label": "", "metadata": {}, "score": "53.93959"}
{"text": "This randomized placebo controlled trial met its primary objective , which was to evaluate the effects of INTUNIV on oppositional symptoms in children aged 6 to 12 years with a diagnosis of ADHD and the presence of oppositional symptoms .", "label": "", "metadata": {}, "score": "54.051178"}
{"text": "Clin Infect Dis .Available at .Cordero E , Pachon J , Rivero A , et al .Community - acquired bacterial pneumonia in human immunodeficiency virus - infected patients : validation of severity criteria .", "label": "", "metadata": {}, "score": "54.16452"}
{"text": "PubMed .Nicolson P , Anderson P : The patient 's burden : physical and psychological effects of acute exacerbations of chronic bronchitis .J Antimicrob Chemother 2000 , 45 : 25 - 32 .", "label": "", "metadata": {}, "score": "54.16909"}
{"text": "Sleep disturbances were reported by 68.6 % of patients , with impact on a mean of 4.1 \u00b1 3.7 nights .The impact of the current AECB episode on daily activities and sleep disturbance in patient subgroups categorized by gender , age , smoking status , concomitant diseases , Anthonisen grade , and number of severe symptoms is presented in Table 2 .", "label": "", "metadata": {}, "score": "54.18032"}
{"text": "Methods .Treatment was repeated every 8 weeks for a total of six courses .Patients were repeatedly assessed clinically and microbiologically during the 48-week treatment period , and for a further 24 weeks ' follow - up .", "label": "", "metadata": {}, "score": "54.31299"}
{"text": "In the ITT population with mucopurulent / purulent sputum , the reduction in the odds of having an exacerbation with moxifloxacin was not statistically significant ( Figure 3B ) .", "label": "", "metadata": {}, "score": "54.335594"}
{"text": "N Engl J Med .Aug 8 1996;335(6):392 - 398 .Oldfield EC , 3rd , Fessel WJ , Dunne MW , et al .Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS : a randomized , double - blind , placebo - controlled multicenter trial .", "label": "", "metadata": {}, "score": "54.38371"}
{"text": "May 21 2004;18(8):1210 - 1213 .Centers for Disease C , Prevention .Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions : recommendations of the Advisory Committee on Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "54.685966"}
{"text": "The absolute bioavailability of moxifloxacin is approximately 90 % .The bactericidal action of moxifloxacin results .Moxifloxacin .Version 30/08/2010 .If stored at cool .", "label": "", "metadata": {}, "score": "54.701027"}
{"text": "Eur J Obstet Gynecol Reprod Biol .Nov 1996;69(2):83 - 89 .Loebstein R , Addis A , Ho E , et al .Pregnancy outcome following gestational exposure to fluoroquinolones : a multicenter prospective controlled study .", "label": "", "metadata": {}, "score": "54.725822"}
{"text": "Apr 1994;49(4):367 - 368 .Mundy LM , Auwaerter PG , Oldach D , et al .Community - acquired pneumonia : impact of immune status .", "label": "", "metadata": {}, "score": "54.842876"}
{"text": "400 mg once daily .218 Must be used in conjunction with other antituberculosis agents .Multiple - drug regimen usually given for 12 - 18 months when rifampin - resistant M. tuberculosis are involved ; for 18 - 24 months when isoniazid- and rifampin - resistant strains are involved ; or for 24 months when the strain is resistant to isoniazid , rifampin , ethambutol , and/or pyrazinamide .", "label": "", "metadata": {}, "score": "54.99716"}
{"text": "S. aureus should be considered in patients with recent viral ( or influenza ) infection ; a history of injection drug use ; or severe , bilateral , necrotizing pneumonia .", "label": "", "metadata": {}, "score": "55.101986"}
{"text": "Preferred beta - lactams are ceftriaxone , cefotaxime , or ampicillin - sulbactam .Preferred macrolides are azithromycin and clarithromycin .Doxycycline is an alternative to the macrolide ( CIII ) .", "label": "", "metadata": {}, "score": "55.130104"}
{"text": "However , studies evaluating quinolone use in pregnant women did not find an increased risk of birth defects or musculoskeletal abnormalities .57,58 Thus , when indicated , quinolones can be used in pregnancy for serious respiratory infections ( CIII ) .", "label": "", "metadata": {}, "score": "55.167694"}
{"text": "The role of respiratory bacterial pathogens in COPD has been clarified in recent years .It is likely that 40 - 50 % of exacerbations are related to bacterial infection , particularly strains that are new to the patient [ 9 ] .", "label": "", "metadata": {}, "score": "55.17115"}
{"text": "Sep 25 2000;160(17):2633 - 2638 .CDC .Recommended Adult Immunization Schedule - United States , October 2007-September 2008 .MMWR 2007;56:Q1-Q4 .", "label": "", "metadata": {}, "score": "55.188934"}
{"text": "CDC surveillance summaries : Morbidity and mortality weekly report .CDC surveillance summaries / Centers for Disease Control .Apr 16 1999;48(2):1 - 22 .Sullivan JH , Moore RD , Keruly JC , al e. Effect of antiretroviral therapy on the incidence of bacterial pneumonial in patients with advanced HIV infection .", "label": "", "metadata": {}, "score": "55.242332"}
{"text": "PubMed ] [ DOI ] .Umgelter A , Reindl W , Miedaner M , Schmid RM , Huber W. Failure of current antibiotic first - line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "55.28406"}
{"text": "There are no studies evaluating the use of combination therapy in patients failing to respond to TMP / SMX .When patients develop progressive disease while on therapy , the explanation is likely to be some combination of host immunity , underlying pulmonary dysfunction , and severity of disease , not drug resistance .", "label": "", "metadata": {}, "score": "55.34613"}
{"text": "[PubMed ] [ DOI ] .Fern\u00e1ndez J , Navasa M , G\u00f3mez J , Colmenero J , Vila J , Arroyo V , Rod\u00e9s J. Bacterial infections in cirrhosis : epidemiological changes with invasive procedures and norfloxacin prophylaxis .", "label": "", "metadata": {}, "score": "55.35395"}
{"text": "Benha Med J .[PubMed ] [ DOI ] .Yakar T , G\u00fc\u00e7l\u00fc M , Serin E , Ali\u015fkan H , Husamettin E. A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis .", "label": "", "metadata": {}, "score": "55.36065"}
{"text": "All the specimens were analyzed within one hour .Moreover , 10 mL of ascitic fluid was inoculated directly at the patient 's bedside into aerobic and anaerobic blood culture bottles for bacteriological examination .", "label": "", "metadata": {}, "score": "55.42785"}
{"text": "Importance of informing clinician of personal or family history of QT interval prolongation or proarrhythmic conditions ( e.g. , recent hypokalemia , bradycardia , AMI ) .", "label": "", "metadata": {}, "score": "55.47077"}
{"text": "PubMed View Article .Pena VS , Miravitlles M , Gabriel R , Jimenez - Ruiz CA , Villasante C , Masa JF , Viejo JL , Fernandez - Fau L : Geographic variations in prevalence and underdiagnosis of COPD : results of the IBERPOC multicentre epidemiological study .", "label": "", "metadata": {}, "score": "55.55937"}
{"text": "Vaccine Dosing : .Preventing Influenza and Bacterial Pneumonia as a Complication of Influenza .Indication for Influenza Vaccination : .Note : Live attenuated influenza vaccine is contraindicated in HIV - infected persons ( AIII ) .", "label": "", "metadata": {}, "score": "55.607384"}
{"text": "1 Metabolic disturbances associated with hepatic insufficiency may lead to QT interval prolongation .Renal Impairment .Common Adverse Effects .Interactions for Moxifloxacin Hydrochloride .", "label": "", "metadata": {}, "score": "55.618282"}
{"text": "Navin TR , Rimland D , Lennox JL , et al .Risk factors for community - acquired pneumonia among persons infected with human immunodeficiency virus .", "label": "", "metadata": {}, "score": "55.65198"}
{"text": "[ IDIS 483635 ] [ PubMed 12117077 ] .Zhanel GG , Palatnick L , Nichol KA et al .Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates : results of the Canadian respiratory organism susceptibility study , 1997 to 2002 .", "label": "", "metadata": {}, "score": "55.65205"}
{"text": "Analyses in the intent - to - treat ( ITT ) population , randomized patients who received at least one dose of study medication , were supportive .", "label": "", "metadata": {}, "score": "55.70009"}
{"text": "Wright JG , Quinn CP , Shadomy S et al .Use of anthrax vaccine in the United States : recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 .", "label": "", "metadata": {}, "score": "55.82875"}
{"text": "N Engl J Med .Sep 28 1995;333(13):845 - 851 .Jones JL , Hanson DL , Dworkin MS , et al .Surveillance for AIDS - defining opportunistic illnesses , 1992 - 1997 .", "label": "", "metadata": {}, "score": "55.863808"}
{"text": "A 13-valent pneumococcal conjugate vaccine ( PCV13 ) has recently been recommended by the Advisory Committee on Immunization Practices for use in adults with immunocompromising conditions , including HIV infection .", "label": "", "metadata": {}, "score": "55.913914"}
{"text": "One case of diarrhoea caused by Clostridium difficile was reported in the placebo group .Table 1 .Incidence of adverse events ( intent - to - treat ( ITT)/safety population ) .", "label": "", "metadata": {}, "score": "55.921295"}
{"text": "Conclusions .Intermittent pulsed therapy with moxifloxacin reduced the odds of exacerbation by 20 % in the ITT population , by 25 % among the PP population and by 45 % in PP patients with purulent / mucopurulent sputum at baseline .", "label": "", "metadata": {}, "score": "55.94195"}
{"text": "Jan 1990;141(1):89 - 93 .Diep BA , Chambers HF , Graber CJ , et al .Emergence of multidrug - resistant , community - associated , methicillin - resistant Staphylococcus aureus clone USA300 in men who have sex with men .", "label": "", "metadata": {}, "score": "55.977364"}
{"text": "Patients who are receiving a macrolide for MAC prophylaxis should never receive macrolide monotherapy for empiric treatment of bacterial pneumonia , but macrolides can be used as part of a combination regimen .", "label": "", "metadata": {}, "score": "56.1184"}
{"text": "Severe illness with nausea and vomiting or high fever .Inability to follow or tolerate outpatient regimen .Pregnancy .If the patient is pregnant , aggressive treatment is essential to prevent preterm delivery , fetal loss , and maternal morbidity .", "label": "", "metadata": {}, "score": "56.127052"}
{"text": "May 28 1998;12(8):885 - 893 .Curran A , Falco V , Crespo M , et al .Bacterial pneumonia in HIV - infected patients : use of the pneumonia severity index and impact of current management on incidence , aetiology and outcome .", "label": "", "metadata": {}, "score": "56.18823"}
{"text": "Molecular typing suggests that repeated episodes of PCP are probably related to acquisition of different strains rather than to reactivation of an existing infection .Pneumocystis is known to be host- species- specific , which suggests that human infection is unlikely to be a zoonosis .", "label": "", "metadata": {}, "score": "56.212055"}
{"text": "2,38,45 - 47 Clinicians should encourage cessation of these behaviors , and data suggest that smoking cessation can decrease the risk of bacterial pneumonia .Treating Disease .", "label": "", "metadata": {}, "score": "56.254936"}
{"text": "The absolute risk reduction in the number of exacerbations experienced during the 48-week study period was 5.7 % and the NNT to prevent one exacerbation was 18 .", "label": "", "metadata": {}, "score": "56.269886"}
{"text": "Treatment with anti - infectives alters normal colon flora and may permit overgrowth of Clostridium difficile .1 76 80 81 96 98 99 C. difficile produces toxins A and B which contribute to development of CDAD ; 1 96 hypertoxin - producing strains of C. difficile are associated with increased morbidity and mortality since they may be refractory to anti - infectives and colectomy may be required .", "label": "", "metadata": {}, "score": "56.31231"}
{"text": "663 668 683 686 Some of these experts state that levofloxacin or other oral fluoroquinolones ( moxifloxacin , ofloxacin ) are alternatives when ciprofloxacin or doxycycline can not be used .", "label": "", "metadata": {}, "score": "56.399635"}
{"text": "55,56 Azithromycin did not produce birth defects in animal studies , but experience with human use in the first trimester is limited .Azithromycin is recommended when a macrolide is indicated in pregnancy ( BIII ) .", "label": "", "metadata": {}, "score": "56.407974"}
{"text": "400 mg daily .PO : .Hartmanns .5 % , 10 % & 40 % dextrose .400 mg daily DOSAGE IN RENAL FAILURE AND RENAL REPLACEMENT THERAPY :", "label": "", "metadata": {}, "score": "56.44198"}
{"text": "INTUNIV Demonstrated Significant Efficacy in Secondary Endpoints .In this randomized , placebo - controlled , flexible - dose study , INTUNIV demonstrated significant ADHD symptom improvement in patients with oppositional symptoms as measured by the ADHD Rating Scale - IV ( ADHD - RS - IV ) , a scale frequently used in ADHD clinical trials .", "label": "", "metadata": {}, "score": "56.457916"}
{"text": "Jun 17 2000;355(9221):2106 - 2111 .Watera C , Nakiyingi J , Miiro G , et al .23-Valent pneumococcal polysaccharide vaccine in HIV - infected Ugandan adults : 6-year follow - up of a clinical trial cohort .", "label": "", "metadata": {}, "score": "56.463173"}
{"text": "Oct 1 2007;45(7):e82 - 87 .Rodriguez - Barradas MC , Goulet J , Brown S , et al .Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study .", "label": "", "metadata": {}, "score": "56.52882"}
{"text": "Table 1 .Patient demographics and disease characteristics at baseline ( efficacy population ) .One - half of patients ( 49.9 % ) complained of an infection of the upper respiratory tract in the past 5 days .", "label": "", "metadata": {}, "score": "56.589558"}
{"text": "Sethi S : Infectious etiology of acute exacerbations of chronic bronchitis .Chest 2000 , 117 ( 5 Suppl 2 ) : 380S-385S. PubMed View Article .", "label": "", "metadata": {}, "score": "56.597565"}
{"text": "Such patients include those with baseline purulent / mucopurulent or purulent sputum production , who are not colonized by P. aeruginosa , and who have an unacceptable frequency of exacerbations in spite of maximal therapy with inhaled agents for COPD or who experience complications such as pneumonia with these treatments .", "label": "", "metadata": {}, "score": "56.612213"}
{"text": "Analysis populations .This trial was designed as a proof - of - concept study to test whether long - term intermittent treatment with an antibiotic would reduce exacerbation frequency in patients with COPD .", "label": "", "metadata": {}, "score": "56.614918"}
{"text": "The mean number of exacerbations in the last 12 months was 2.7 and 26.3 % of patients had been hospitalized at least once for exacerbation .", "label": "", "metadata": {}, "score": "56.90054"}
{"text": "Clinical and laboratory assessment .These were performed in all the cirrhotic patients with ascites on the day of admission and whenever they developed symptoms and signs suspicious for SBP ( i.e . , fever , change in mental status , abdominal pain , development of renal failure , hypotension , etc . ) during the hospitalization period .", "label": "", "metadata": {}, "score": "56.974297"}
{"text": "Lung function .Data show the percentage predicted FEV 1 during the 48 weeks of treatment with moxifloxacin or placebo in the per - protocol end - of - treatment ( PP EOT ) and intent - to - treat ( ITT ) populations .", "label": "", "metadata": {}, "score": "57.15072"}
{"text": "Clinical and Laboratory Standards Institute and U.S. Food and Drug Administration changes in the penicillin breakpoints for treatment of non - meningitis pneumococcal disease imply that clinicians can consider treatment with IV penicillin in HIV - infected patients confirmed to have pneumococcal pneumonia ( BIII ) .", "label": "", "metadata": {}, "score": "57.2864"}
{"text": "Conclusions .A significant number of patients in this observational study had risk factors for poor outcome , justifying use of moxifloxacin .The safety profile of moxifloxacin and its value as an antibiotic treatment were confirmed .", "label": "", "metadata": {}, "score": "57.294643"}
{"text": "Treatment .Because clinical diagnostic criteria for PID are not always conclusive , presumptive diagnosis and early empiric treatment is common .The positive predictive value of a clinical diagnosis is 65 - 90 % .", "label": "", "metadata": {}, "score": "57.372787"}
{"text": "The detection of P. aeruginosa with a higher MIC during the study than those present at screening / randomization suggests that patients colonized by this organism in the airway should not be considered for the therapeutic regimen described in this study .", "label": "", "metadata": {}, "score": "57.37362"}
{"text": "Jun 15 2005;191(12):2038 - 2045 .Grau I , Pallares R , Tubau F , et al .Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "57.470364"}
{"text": "Many studies have documented no difference in length or severity of lower abdominal pain , vaginal discharge , fever , abnormal vaginal bleeding , or low back pain between HIV - infected and HIV - uninfected women with PID .", "label": "", "metadata": {}, "score": "57.599804"}
{"text": "Please Select a Guideline Adult and Adolescent Guidelines Pediatric Guidelines Perinatal Guidelines Prevention and Treatment of Opportunistic Infections Guidelines Pediatric OI Prevention and Treatment Guidelines Residents Displaced from Disaster Areas .", "label": "", "metadata": {}, "score": "57.64654"}
{"text": "View Article PubMed .Vincken W , van Noord JA , Greefhorst AP , Bantje TA , Kesten S , Korducki L , Cornelissen PJ , Dutch / Belgian Tiotropium Study Group : Improved health outcomes in patients with COPD during 1 yr 's treatment with tiotropium .", "label": "", "metadata": {}, "score": "57.692"}
{"text": "2001 ; 40 ( suppl 1):19 - 25 [ PubMed 11352438 ] .Stass H , Kubitza D. Effects of dairy products on the oral bioavailability of moxifloxacin , a novel 8-methoxyfuloroquinolone , in healthy volunteers .", "label": "", "metadata": {}, "score": "57.70002"}
{"text": "17 Other studies have highlighted the declining incidence of pneumococcal bacteremia in the era of ART . 18 .Bacterial pneumonia is associated with increased mortality in HIV - infected individuals .", "label": "", "metadata": {}, "score": "57.75289"}
{"text": "Apr 1996;173(4):857 - 862 .Guerrero M , Kruger S , Saitoh A , et al .Pneumonia in HIV - infected patients : a case - control survey of factors involved in risk and prevention .", "label": "", "metadata": {}, "score": "57.8341"}
{"text": "400 mg in 250ml solution ( pre - mixed bag ) Remove from aluminium overwrap bag immediately before us .temperatures precipitation may occur - this will redissolve at room temperature .", "label": "", "metadata": {}, "score": "57.85762"}
{"text": "Inactivated influenza vaccine should be administered annually during influenza season to all HIV - infected individuals ( AIII ) .40This recommendation is pertinent to prevention of bacterial pneumonia , which can occur as a complication of influenza .", "label": "", "metadata": {}, "score": "57.876328"}
{"text": "Active against some strains of M. tuberculosis resistant to isoniazid , rifampin , or streptomycin , 24 28 but moxifloxacin - resistant M. tuberculosis have been reported and some multidrug - resistant strains ( i.e. , strains resistant to rifampin and isoniazid ) also are resistant to moxifloxacin or other fluoroquinolones .", "label": "", "metadata": {}, "score": "57.89361"}
{"text": "View Article PubMed .Hill AT , Campbell EJ , Hill SL , Bayley DL , Stockley RA : Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis .", "label": "", "metadata": {}, "score": "58.01107"}
{"text": "1465 - 9921 - 11 - 10-S5.DOC Additional file 5 : Demographic , clinical and medical characteristics at baseline .Demographic data on the per - protocol and the intent - to - treat populations .", "label": "", "metadata": {}, "score": "58.022163"}
{"text": "[ PubMed 16776446 ] .Aubry A , Veziris N , Cambau E et al .Novel gyrase mutations in quinolone - resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis : functional analysis of mutant enzymes .", "label": "", "metadata": {}, "score": "58.057587"}
{"text": "29 ] .Incidences of TEAEs and drug - related adverse events were low .The incidence of TEAEs was lower in the current study than reported in controlled clinical studies ( e.g. [ 34 ] ) , which may be attributed to an underreporting of mild / moderate adverse events that is a feature of observational studies .", "label": "", "metadata": {}, "score": "58.14061"}
{"text": "Ann Intern Med 2005 , 143 : 317 - 326 .PubMed .Calverley PMA , Anderson JA , Celli B , Ferguson GT , Jenkins C , Jones PW , Yates JC , Vestbo J , TORCH investigators : Salmeterol and fluticasone proprionate and survival in chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "58.208992"}
{"text": "May 7 2004;22(15 - 16):2006 - 2012 .French N , Nakiyingi J , Carpenter LM , et al .23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults : double - blind , randomised and placebo controlled trial .", "label": "", "metadata": {}, "score": "58.300343"}
{"text": "Seemungal TA , Donaldson GC , Paul EA , Bestall JC , Jeffries DJ , Wedzicha JA : Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "58.39862"}
{"text": "Patients who fail to respond to appropriate antimicrobial therapy should undergo further evaluation to search for other infectious and noninfectious causes of pulmonary dysfunction .The possibility of TB should always be considered in HIV - infected patients with pulmonary disease .", "label": "", "metadata": {}, "score": "58.43144"}
{"text": "This rapid expansion is followed , after a year or more of therapy , by a gradual , selective rise in na\u00efve T - cells .", "label": "", "metadata": {}, "score": "58.45564"}
{"text": "After 5 days , 93.2 % of patients reported improvement and , in total , 93.5 % of patients were symptom - free after 10 days .", "label": "", "metadata": {}, "score": "58.59111"}
{"text": "History of recent intrauterine device ( IUD ) placement ( the risk of PID associated with IUD use is confined primarily to the first 3 weeks after insertion ) .", "label": "", "metadata": {}, "score": "58.611897"}
{"text": "Available at .Serraino D , Puro V , Boumis E , et al .Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS : Europe , 1993 - 2000 .", "label": "", "metadata": {}, "score": "58.82322"}
{"text": "That 's the good news .The bad news is that OIs continue to pose a threat to individuals with advanced HIV disease .There have , for example , been reports of fulminant CMV retinitis in patients whose CD4 counts had risen , as a result of highly active antiretroviral therapy , well above the supposed threshold level for breakthrough infections .", "label": "", "metadata": {}, "score": "58.831226"}
{"text": "That is why cefotaxime as an empirical therapy should be begun without delay .In the cefotaxime sensitive group gram negative bacteria were the most frequent ( 22/26 ; 85 % ) and E. coli was the most predominant ; however Gram positive bacteria were isolated in 4 patients .", "label": "", "metadata": {}, "score": "58.848328"}
{"text": "Jan 1997;155(1):72 - 80 .Hirschtick RE , Glassroth J , Jordan MC , et al .Bacterial pneumonia in persons infected with the human immunodeficiency virus .", "label": "", "metadata": {}, "score": "59.009174"}
{"text": "View Article PubMed .Copyright .\u00a9 Sethi et al .2010 .This article is published under license to BioMed Central Ltd. Shire 's INTUNIV ( Guanfacine ) extended release in children with ADHD and oppositional symptoms .", "label": "", "metadata": {}, "score": "59.034935"}
{"text": "Trial registration .ClinicalTrials.gov identifier : NCT00846911 .Keywords .Antibiotics Chronic bronchitis COPD Exacerbations Moxifloxacin .Background .Acute exacerbations of chronic bronchitis ( AECB ) , including chronic obstructive pulmonary disease ( AECOPD ) , represent a substantial disease burden to patients , contributing to reduced lung function , increased morbidity and mortality , and long - term impairment in quality of life [ 1 - 8 ] .", "label": "", "metadata": {}, "score": "59.45865"}
{"text": "\" On January 26 , 2009 , Shire filed a resubmission to the US Food and Drug Administration ( FDA ) of the New Drug Application to support approval for the treatment of ADHD in children and adolescents .", "label": "", "metadata": {}, "score": "59.492622"}
{"text": "At EOT there was an absolute risk reduction of 5.5 % for exacerbations experienced during the 48-week study period .The NNT to prevent one exacerbation is 19 .", "label": "", "metadata": {}, "score": "59.75876"}
{"text": "In one randomized , controlled trial , use of ART early in the course of OIs , including bacterial infections , led to less AIDS progression and death compared with later onset of therapy .", "label": "", "metadata": {}, "score": "59.79299"}
{"text": "Live attenuated influenza vaccine should not be used in HIV - infected persons ( AIII ) .Because administration of vaccines can be associated with a transient rise in plasma HIV RNA levels , vaccination of pregnant women is recommended after ART has been initiated to minimize increases in plasma HIV RNA levels that might increase the risk of perinatal transmission of HIV .", "label": "", "metadata": {}, "score": "59.806095"}
{"text": "Changes in lung function .Values are adjusted mean change of percentage predicted FEV 1 over time in the per - protocol end - of - treatment ( PP EOT ) and intent - to - treat ( ITT ) populations .", "label": "", "metadata": {}, "score": "59.80787"}
{"text": "S. aureus , P. aeruginosa , M. catarrhalis , and K. pneumoniae were isolated less frequently ( from 2.6 % , 2.4 % , 2.0 % , and 2.0 % , of the PP EOT population , respectively ) .", "label": "", "metadata": {}, "score": "60.036236"}
{"text": "Trial registration .ClinicalTrials.gov number , NCT00473460 ( ClincalTrials.gov ) .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "60.08146"}
{"text": "View Article PubMed .Wedzicha JA , Calverley PM , Seemungal TA , Hagan G , Ansari Z , Stockley RA , INSPIRE Investigators : The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol / fluticasone propionate or tiotropium bromide .", "label": "", "metadata": {}, "score": "60.196213"}
{"text": "31 A third dose of PPV23 should be given at age 65 years or later , as long as 5 years have elapsed since the most recent dose and it was given before age 65 years ( BIII ) .", "label": "", "metadata": {}, "score": "60.33259"}
{"text": "View Article PubMed .Sethi S , Wrona C , Eschberger K , Lobbins P , Cai X , Murphy TF : Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "60.350166"}
{"text": "A left shift in WBC differential may be present .Individuals with bacterial pneumonia characteristically exhibit unilateral , focal , segmental , or lobar consolidation on chest radiograph .", "label": "", "metadata": {}, "score": "60.381844"}
{"text": "[ PubMed 16322602 ] .Centers for Disease Control and Prevention .Severe Clostridium difficile -associated disease in populations previously at low risk - four states , 2005 .", "label": "", "metadata": {}, "score": "60.49717"}
{"text": "JAMA .[ IDIS 480001 ] [ PubMed 11980524 ] .Griffith DE , Aksamit T , Brown - Elliott BA et al .An official ATS / IDSA statement : diagnosis , treatment , and prevention of nontuberculous mycobacterial diseases .", "label": "", "metadata": {}, "score": "60.77318"}
{"text": "Fluoroquinolones , including moxifloxacin , cause arthropathy and osteochondrosis in immature animals of various species . 1 88 89 90 91 92 93 94 95 97 Permanent lesions in cartilage reported in moxifloxacin studies in immature dogs .", "label": "", "metadata": {}, "score": "60.92286"}
{"text": "The organization works closely with area homeless families to fulfill ... .( Date:2/11/2016 ) ... -- - Cardiac Marker Diagnostic Testing ...Cancer Therapy .", "label": "", "metadata": {}, "score": "61.09652"}
{"text": "Electronic supplementary material .1465 - 9921 - 11 - 10-S1.DOC Additional file 1 : Inclusion and exclusion criteria .List of criteria used to include or exclude patients from the trial .", "label": "", "metadata": {}, "score": "61.10897"}
{"text": "PubMed View Article .Behrendt CE : Mild and moderate - to - severe COPD in nonsmokers : distinct demographic profiles .Chest 2005 , 128 ( 3 ) : 1239 - 1244 .", "label": "", "metadata": {}, "score": "61.138233"}
{"text": "Secondary efficacy outcomes included hospitalization and mortality , changes in disease - related health status assessed with the SGRQ and changes in lung function measured as % PFEV 1 .", "label": "", "metadata": {}, "score": "61.14077"}
{"text": "Apr 2000;117(4):1017 - 1022 .Park DR , Sherbin VL , Goodman MS .The etiology of community - acquired pneumonia at an urban public hospital : influence of human immunodeficiency virus infection and initial severity of illness .", "label": "", "metadata": {}, "score": "61.3599"}
{"text": "1465 - 9921 - 11 - 10-S3.DOC Additional file 3 : Definitions of exacerbations .Definitions of acute exacerbation of chronic bronchitis ( AECB ) and pneumonia .", "label": "", "metadata": {}, "score": "61.415756"}
{"text": "Although pneumocystis is less of a threat to people with HIV than it once was , PCP still causes significant morbidity and mortality in this population .", "label": "", "metadata": {}, "score": "61.500324"}
{"text": "Nucleic acid amplification tests ( NAAT ) or culture for GC and CT .Microscopic examination of saline preparation of vaginal secretions .Often , diagnosis must be made and treatment initiated on the basis of clinical criteria .", "label": "", "metadata": {}, "score": "61.51269"}
{"text": "They were randomized by matching the sample ( resistant group ) and were classified into matched pairs ; one from each pair was randomly enrolled into either the meropenem subgroup or the levofloxacin subgroup .", "label": "", "metadata": {}, "score": "61.6428"}
{"text": "Wald ER , Applegate KE , Bordley C et al .Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1 to 18 Years .", "label": "", "metadata": {}, "score": "61.774612"}
{"text": "PubMed View Article .Donaldson GC , Seemungal TA , Bhowmik A , Wedzicha JA : Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "61.833084"}
{"text": "The increased incidence of bacteremia in HIV - infected patients , especially those with low CD4 cell counts , and the high specificity of blood cultures argue for their collection in such individuals .", "label": "", "metadata": {}, "score": "61.92292"}
{"text": "The secondary definition included any confirmed AECB ( but excluded confirmed / unconfirmed pneumonia and any other LRTIs ) , minimally 2 weeks between start of two consecutive exacerbations whether or not intervention was documented .", "label": "", "metadata": {}, "score": "61.960457"}
{"text": "Secondary outcomes : Area of erythema , days of treatment , side - effects of medication , cost of treatment , patient satisfaction , relapse at 14 days .", "label": "", "metadata": {}, "score": "62.02336"}
{"text": "The increased incidence of P. aeruginosa and S. aureus ( including community - acquired MRSA ) as causes of CAP are exceptions .Both of these pathogens occur in specific epidemiologic patterns with distinct clinical presentations , for which empiric antibiotic coverage may be warranted .", "label": "", "metadata": {}, "score": "62.178665"}
{"text": "The most frequently used non - AECB - related comedications were for the treatment of cardiovascular symptoms ( 36.1 % of patients ) , dermatological diseases ( 23.0 % ) , dysfunction of the alimentary tract and metabolism ( 22.2 % ) , and ophthalmological diseases ( 20.5 % ) .", "label": "", "metadata": {}, "score": "62.19081"}
{"text": "It is possible that sputum purulence is also a marker for chronic bronchial infection in stable COPD , thereby explaining the greater benefit with prophylactic antibiotic treatment in these patients .", "label": "", "metadata": {}, "score": "62.273956"}
{"text": "Intra - abdominal Infections .Treatment of complicated intra - abdominal infections ( including polymicrobial infections such as abscess ) caused by susceptible Bacteroides fragilis , B. thetaiotaomicron , Clostridium perfringens , Enterococcus faecalis , E. coli , Proteus mirabilis , S. anginosus , S. constellatus , or Peptostreptococcus .", "label": "", "metadata": {}, "score": "62.344666"}
{"text": "Symptoms listed above , and duration .Sexual history including new sex partner(s ) and episodes of unprotected sex .Last menstrual period .Previous diagnosis of gonorrhea or chlamydia .", "label": "", "metadata": {}, "score": "62.414597"}
{"text": "Guidelines for diagnosing and managing community - acquired pneumonia ( CAP ) in individuals who are not HIV infected also apply to those who are infected .", "label": "", "metadata": {}, "score": "62.43259"}
{"text": "PubMed View Article .Spencer S , Jones PW : Time course of recovery of health status following an infective exacerbation of chronic bronchitis .Thorax 2003 , 58 ( 7 ) : 589 - 593 .", "label": "", "metadata": {}, "score": "62.434574"}
{"text": "[PubMed ] [ DOI ] .Salerno F , Gerbes A , Gin\u00e8s P , Wong F , Arroyo V. Diagnosis , prevention and treatment of hepatorenal syndrome in cirrhosis .", "label": "", "metadata": {}, "score": "62.4898"}
{"text": "Albumin use was suggested in SBP management [ 25 ] , although it was not included in the treatment protocols .However the guidelines for the prevention and treatment of hepato - renal syndrome [ 26 ] suggested that albumin administration may reduce the incidence of renal failure and mortality in patients with SBP ; consequently , all our patients received albumin .", "label": "", "metadata": {}, "score": "62.50947"}
{"text": "[PubMed ] [ DOI ] .Tandon P , Garcia - Tsao G. Bacterial infections , sepsis , and multiorgan failure in cirrhosis .Semin Liver Dis .", "label": "", "metadata": {}, "score": "62.52132"}
{"text": "Treatment of community - acquired pneumonia ( CAP ) caused by susceptible S. pneumoniae ( including multidrug - resistant strains ) , S. aureus ( oxacillin - susceptible [ methicillin - susceptible ] strains ) , K. pneumoniae , H. influenzae , M. catarrhalis , Mycoplasma pneumoniae , or Chlamydophila pneumoniae ( formerly Chlamydia pneumoniae ) .", "label": "", "metadata": {}, "score": "62.598854"}
{"text": "Wallace JM , Hansen NI , Lavange L , et al .Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort .Pulmonary Complications of HIV Infection Study Group .", "label": "", "metadata": {}, "score": "62.600845"}
{"text": "In contrast , a pre - treatment expectorated sputum specimen for Gram stain and culture and two blood cultures should be obtained from HIV - infected patients hospitalized for suspected CAP , particularly those who require intensive care .", "label": "", "metadata": {}, "score": "62.63285"}
{"text": "Jan 1999;13(1):175 - 179 .Levine SJ , White DA , Fels AO .The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus .", "label": "", "metadata": {}, "score": "62.81926"}
{"text": "For patients begun on IV antibiotic therapy , switching to PO should be considered when patient is clinically improved and able to tolerate oral medications .", "label": "", "metadata": {}, "score": "62.903168"}
{"text": "Clinical Manifestations .Clinical and radiographic presentation of bacterial pneumonia in HIV - infected individuals is similar to that in those who are not HIV infected .", "label": "", "metadata": {}, "score": "62.95271"}
{"text": "Jan 2000;181(1):158 - 164 .Justice AC , Lasky E , McGinnis KA , et al .Medical disease and alcohol use among veterans with human immunodeficiency infection : A comparison of disease measurement strategies .", "label": "", "metadata": {}, "score": "63.024956"}
{"text": "Sep 26 2003;17(14):2109 - 2116 .Polsky B , Gold JW , Whimbey E , et al .Bacterial pneumonia in patients with the acquired immunodeficiency syndrome .", "label": "", "metadata": {}, "score": "63.029217"}
{"text": "American Thoracic Society and the Infectious Diseases Society of America .Guidelines for the management of adults with hospital - acquired , ventilator - associated , and healthcare - associated pneumonia .", "label": "", "metadata": {}, "score": "63.072884"}
{"text": "View Article PubMed .Am J Respir Crit Care Med 2008 , 178 : 332 - 338 .View Article PubMed .Seemungal TA , Donaldson GC , Paul EA , Bestall JC , Jeffries DJ , Wedzicha JA : Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "63.08065"}
{"text": "Jan 1986;104(1):38 - 41 .Burack JH , Hahn JA , Saint - Maurice D , Jacobson MA .Microbiology of community - acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection .", "label": "", "metadata": {}, "score": "63.153103"}
{"text": "1465 - 9921 - 11 - 10-S4.DOC Additional file 4 : Statistical analysis .Gives the model used for the statistical analysis and describes how missing data were handled .", "label": "", "metadata": {}, "score": "63.208794"}
{"text": "However , patients with HIV infection are at increased risk of infection with drug - resistant pneumococci .25,26 Because identification of this organism could lead to changes in management , collection of blood specimens in HIV - infected patients with CAP should always be considered .", "label": "", "metadata": {}, "score": "63.482048"}
{"text": "Afr J Microbiol Res .[PubMed ] [ DOI ] .Levison ME , Bush LM .Peritonitis and intraperitoneal abcesses .Principles and Practice of Infectious Diseases .", "label": "", "metadata": {}, "score": "63.542763"}
{"text": "The frequency of Pseudomonas aeruginosa and Staphylococcus aureus as community - acquired pathogens is higher in HIV - infected individuals than in those not HIV infected .", "label": "", "metadata": {}, "score": "63.57677"}
{"text": "This article emphasises the value of meropenem and levofloxacin as effective alternatives to cefotaxime in resistant cases .Terminology .Spontaneous bacterial peritonitis is infection of ascitic fluid in patients with cirrhosis ; Cefotaxime ( a third generation cephalosporin ) is utilized primarily for its activity against Gram - negative aerobic organisms .", "label": "", "metadata": {}, "score": "63.659782"}
{"text": "Sexually transmitted diseases , HIV , and AIDS in women .In : The Medical Clinics of North America , vol .Handsfield HH , Sparling PF .", "label": "", "metadata": {}, "score": "63.68609"}
{"text": "Secondary efficacy outcomes were analysed as follows .Hospitalization and mortality were analysed by Fisher 's exact test .Changes in lung function measured by % PFEV 1 were analysed using a repeated measures ANOVA adjusted for region , visit , treatment group , and the interaction term between treatment and visit .", "label": "", "metadata": {}, "score": "63.82322"}
{"text": "View Article PubMed .Sethi S , Maloney J , Grove L , Wrona C , Berenson CS : Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "63.91973"}
{"text": "Sep 2008;79(3):320 - 330 .Dworkin MS , Hanson DL , Navin TR .Survival of patients with AIDS , after diagnosis of Pneumocystis carinii pneumonia , in the United States .", "label": "", "metadata": {}, "score": "64.218636"}
{"text": "[PubMed ] [ DOI ] .Paterson DL .Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended - spectrum beta - lactamases ( ESBLs ) .", "label": "", "metadata": {}, "score": "64.225174"}
{"text": "Patient population .A total of 2672 patients were enrolled in the study and included in the safety population .Demographic and disease characteristics of the efficacy population at baseline are presented in Table 1 .", "label": "", "metadata": {}, "score": "64.23244"}
{"text": "PCP is typically diagnosed by visualization of the organisms in clinical samples of induced sputum and/or bronchoalveolar lavage using immunofluorescence or Giemsa , toluidine blue , or Gomori methenamine silver stains ( Figure ) .", "label": "", "metadata": {}, "score": "64.31477"}
{"text": "Data sources include Micromedex \u00ae ( updated Jan 25th , 2016 ) , Cerner Multum \u2122 ( updated Feb 1st , 2016 ) , Wolters Kluwer \u2122 ( updated Feb 1st , 2016 ) and others .", "label": "", "metadata": {}, "score": "64.38684"}
{"text": "Oct 29 2008;26(46):5830 - 5834 .Fiore AE , Uyeki TM , Broder K , et al .Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2010 .", "label": "", "metadata": {}, "score": "64.448685"}
{"text": "May 1 2001;183(9):1409 - 1412 .Gebo KA , Moore RD , Keruly JC , Chaisson RE .Risk factors for pneumococcal disease in human immunodeficiency virus - infected patients .", "label": "", "metadata": {}, "score": "64.50272"}
{"text": "Those with pneumonia due to S. pneumoniae or Haemophilus typically present with consolidation , whereas presence of cavitation may be a feature more suggestive of P. aeruginosa or S. aureus .", "label": "", "metadata": {}, "score": "64.60525"}
{"text": "Clinical presentation may include salpingitis , endometritis , tubal and ovarian abscess , and pelvic peritonitis , although PID may present with subtle or mild symptoms even in HIV - infected women .", "label": "", "metadata": {}, "score": "64.74954"}
{"text": "Clin Infect Dis .Sep 1999;29(3):536 - 543 .Kohli R , Lo Y , Homel P , Flanigan TP , Gardner L , Howard , AA , Rompalo , AM , Moskaleva , G , Schuman , P , and Schoenbaum , EE .", "label": "", "metadata": {}, "score": "64.75282"}
{"text": "Lancet .May 1 1999;353(9163):1463 - 1468 .Hardy WD , Feinberg J , Finkelstein DM , et al .A controlled trial of trimethoprim - sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome .", "label": "", "metadata": {}, "score": "64.92404"}
{"text": "No effective means exist to reduce exposure to S. pneumoniae and Haemophilus influenzae , which are common in the community .Preventing Disease .Vaccination against S. pneumoniae and influenza , use of combination ART , and lifestyle modifications are all important measures in preventing bacterial pneumonia .", "label": "", "metadata": {}, "score": "64.943726"}
{"text": "Methods .In addition to safety and efficacy outcomes , data on risk factors and the impact of exacerbation on daily life were collected .Results .", "label": "", "metadata": {}, "score": "64.9758"}
{"text": "In HIV - infected patients , particularly those infected with S. pneumoniae , incidence of bacteremia accompanying pneumonia is increased compared with that in individuals who are not HIV infected .", "label": "", "metadata": {}, "score": "64.985825"}
{"text": "Caroline Schneider and Klaus Hechenbichler at the Dr. Schauerte Contract Research organization provided project management and statistical support .Bill Wolvey at PAREXEL provided medical writing support funded by Bayer Pharma .", "label": "", "metadata": {}, "score": "65.24314"}
{"text": "Notable demographic and disease characteristics of this population from South Eastern / Eastern Europe include a markedly higher incidence of COPD among non - smokers when compared with data from Western Europe and the USA [ 37 - 39 ] .", "label": "", "metadata": {}, "score": "65.35454"}
{"text": "One study suggested that the site of care decision be dictated by considering the PSI and CD4 count together .49 In fact , in one series of 118 HIV - infected patients with CAP who were hospitalized , 62 % fell into PSI Classes I and II , groups that are rarely hospitalized if not HIV infected .", "label": "", "metadata": {}, "score": "65.49527"}
{"text": "Jan 4 2002;16(1):85 - 95 .Tarp B , Jensen JS , Ostergaard L , Andersen PL .Search for agents causing atypical pneumonia in HIV - positive patients by inhibitor - controlled PCR assays .", "label": "", "metadata": {}, "score": "65.52765"}
{"text": "Overall population .Figures 2A and 2B illustrate the distribution of the number of exacerbations for the PP EOT and the ITT populations , respectively .", "label": "", "metadata": {}, "score": "65.53839"}
{"text": "The presence of bacteria in the airways in stable COPD , long thought to be innocuous , may also contribute to COPD pathogenesis by causing inflammation and thereby structural airway damage [ 12 - 16 ] .", "label": "", "metadata": {}, "score": "65.581566"}
{"text": "PubMed .Soler - Cataluna JJ , Martinez - Garcia MA , Roman SP , Salcedo E , Navarro M , Ochando R : Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "65.58279"}
{"text": "Discussion .A special feature of the study is the well - documented patient history regarding previous AECBs , concomitant diseases , and comedications related both to the underlying respiratory disease as well as to other comorbidities before study entry .", "label": "", "metadata": {}, "score": "65.6084"}
{"text": "A total of 49.1 % of patients were symptom - free after 5 days , 77.6 % after 7 days , 93.5 % after 10 days , and 98.3 % after 20 days ( Figure 2 ) .", "label": "", "metadata": {}, "score": "65.726814"}
{"text": "Absorption .Bioavailability .Peak plasma concentrations attained within 0.5 - 4 hours ; steady - state attained after at least 3 days .Food .", "label": "", "metadata": {}, "score": "65.77623"}
{"text": "Conclusions .Prevention of acute and chronic infection in COPD would be best achieved by augmenting the innate and adaptive immune responses with vaccines and novel drugs .", "label": "", "metadata": {}, "score": "65.78106"}
{"text": "A strength of observational studies is that they provide an important accompaniment to randomized controlled trials and reflect real - world practice in terms of prescribing behavior [ 41 ] .", "label": "", "metadata": {}, "score": "65.900925"}
{"text": "The primary analysis population was PP EOT , for which 351 and 387 patients in the moxifloxacin- and placebo - treated groups were eligible .Reasons for exclusion from the PP EOT population were similar between the moxifloxacin and placebo treatment arms ( Figure 1 ) .", "label": "", "metadata": {}, "score": "65.92487"}
{"text": "Abstract .Background .Acute exacerbations of chronic bronchitis ( AECB ) , including chronic obstructive pulmonary disease ( AECOPD ) , represent a substantial patient burden .", "label": "", "metadata": {}, "score": "66.03653"}
{"text": "PubMed .Soler - Catalu\u00f1a JJ , Mart\u00ednez - Garc\u00eda MA , Rom\u00e1n S\u00e1nchez P , Salcedo E , Navarro M , Ochando R : Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "66.094864"}
{"text": "Oct 2008;9(8):609 - 615 .Mandell LA , Wunderink RG , Anzueto A , et al .Infectious Diseases Socitey of America , American Thoracic Society .", "label": "", "metadata": {}, "score": "66.09547"}
{"text": "Clinical manifestations of SBP are nonspecific ; the most frequently encountered symptoms and signs are fever ( 69 % ) and abdominal pain ( 59 % ) , [ 14 ] .", "label": "", "metadata": {}, "score": "66.09788"}
{"text": "PubMed .Donaldson GC , Seemungal TA , Bhowmik A , Wedzicha JA : Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "66.130615"}
{"text": "Concomitant diseases of special interest recorded by investigators included COPD ( 66.0 % of patients ) , emphysema ( 23.8 % ) , asthma ( 16.6 % ) , cardiac ischemia ( 23.1 % ) , cor pulmonale ( 10.6 % ) , and diabetes ( 10.1 % ) .", "label": "", "metadata": {}, "score": "66.177895"}
{"text": "The low proportion of positive ascitic fluid cultures is probably due to the relatively low concentration of bacteria in the ascitic fluid as compared with the infections in other organic fluids ( e.g . , urine ) [ 18 ] .", "label": "", "metadata": {}, "score": "66.266045"}
{"text": "2008 Sep;92(5):1083 - 113 , x. .Keep in Touch .No percentage of this project was financed with non - governmental sources .This information or content and conclusions are those of the authors and should not be construed as the official position or policy of , nor should any endorsements be inferred by HRSA , HHS or the U.S. Government .", "label": "", "metadata": {}, "score": "66.31297"}
{"text": "2013 : 132:e262 - 80 .; : .Panel on Opportunistic Infections in HIV - infected Adults and Adolescents .Guidelines for prevention and treatment of opportunistic infections in HIV - infected adults and adolescents : recommendations from the Centers for Disease Control and Prevention , the National Institutes of Health , and the HIV Medicine Association of the Infectious Diseases Society of America ( May 7 , 2013 ) .", "label": "", "metadata": {}, "score": "66.38089"}
{"text": "All women who are diagnosed with PID should be tested for GC and CT . .S : Subjective .The patient may complain of mild - to - moderate lower abdominal pain and tenderness , pain with intercourse , vaginal discharge , fever , chills , heavy menstrual bleeding , or other abnormal vaginal bleeding .", "label": "", "metadata": {}, "score": "66.53282"}
{"text": "To date , the results of these assays have been disappointing , with sensitivities varying from zero to 100 % in different studies of the same assay .", "label": "", "metadata": {}, "score": "66.547035"}
{"text": "Am J Respir Crit Care Med .Dec 2000;162(6):2063 - 2068 .Selwyn PA , Pumerantz AS , Durante A , et al .Clinical predictors of Pneumocystis carinii pneumonia , bacterial pneumonia and tuberculosis in HIV - infected patients .", "label": "", "metadata": {}, "score": "66.598785"}
{"text": "Diagnostic thoracentesis should be considered in all patients with pleural effusion , especially if concern exists for accompanying empyema , and therapeutic thoracentesis should be performed to relieve respiratory distress secondary to a moderate - to - large - sized pleural effusion .", "label": "", "metadata": {}, "score": "66.656494"}
{"text": "View Article PubMed .Am J Respir Crit Care Med 2007 , 176 : 532 - 555 .View Article PubMed .Sethi S , Evans N , Grant BJ , Murphy TF : New strains of bacteria and exacerbations of chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "66.769684"}
{"text": "Oct 1995;152(4 Pt 1):1309 - 1315 .Afessa B , Green B. Bacterial pneumonia in hospitalized patients with HIV infection : the Pulmonary Complications , ICU Support , and Prognostic Factors of Hospitalized Patients with HIV ( PIP ) Study .", "label": "", "metadata": {}, "score": "66.82747"}
{"text": "Arch Intern Med .Miller RF , Foley NM , Kessel D , Jeffrey AA .Community acquired lobar pneumonia in patients with HIV infection and AIDS .", "label": "", "metadata": {}, "score": "66.855484"}
{"text": "JAMA .[ IDIS 446671 ] [ PubMed 10807389 ] .About .Terms & Privacy .Connect .Subscribe to receive email notifications whenever new articles are published .", "label": "", "metadata": {}, "score": "66.92352"}
{"text": "View Article PubMed .Sethi S , Murphy TF : Infection in the pathogenesis and course of chronic obstructive pulmonary disease .N Engl J Med 2008 , 359 : 2355 - 2365 .", "label": "", "metadata": {}, "score": "67.07594"}
{"text": "Soler N , Agusti C , Angrill J , Puig De la Bellacasa J , Torres A : Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "67.14581"}
{"text": "Pneumonia during pregnancy is associated with increased rates of preterm labor and delivery .Pregnant women with pneumonia after 20 weeks ' gestation should be monitored for evidence of contractions ( BII ) .", "label": "", "metadata": {}, "score": "67.15097"}
{"text": "Achieve microbiological cure .Prevent development of permanent tubal damage with associated problems , such as chronic pelvic pain , ectopic pregnancy , and infertility .", "label": "", "metadata": {}, "score": "67.17037"}
{"text": "27 - 32 Several studies also have documented an association between vaccination and a reduced risk of pneumococcal bacteremia .18,32 One randomized placebo - controlled trial of PPV in Africa paradoxically found that vaccination was associated with an increased risk of pneumonia .", "label": "", "metadata": {}, "score": "67.2314"}
{"text": "If previous radiographs are available , they should be reviewed to assess for presence of new findings .The clinical diagnosis of bacterial pneumonia requires a demonstrable infiltrate .", "label": "", "metadata": {}, "score": "67.27425"}
{"text": "May 2006;107(5):1120 - 1138 .Affiliated with .Abstract .Background .Acute exacerbations contribute to the morbidity and mortality associated with chronic obstructive pulmonary disease ( COPD ) .", "label": "", "metadata": {}, "score": "67.38934"}
{"text": "View Article PubMed .Andersson F , Borg S , Jansson SA , Jonsson AC , Ericsson A , Pr\u00fctz C , R\u00f6nmark E , Lundb\u00e4ck B : The costs of exacerbations in chronic obstructive pulmonary disease ( COPD ) .", "label": "", "metadata": {}, "score": "67.39803"}
{"text": "RESULTS .General characteristics and clinical presentation .Baseline characteristics of patients are presented in Table 1 .Age and gender were comparable in group I and group II .", "label": "", "metadata": {}, "score": "67.504845"}
{"text": "PLoS One .2010;5(1):e8896 .Madeddu G , Laura Fiori M , Stella Mura M. Bacterial community - acquired pneumonia in HIV - infected patients .", "label": "", "metadata": {}, "score": "67.54942"}
{"text": "2010 ; 59(RR-6):1 - 30 .[ PubMed 20651644 ] .Inglesby TV , O'Toole T , Henderson DA et al for the Working Group on Civilian Biodefense .", "label": "", "metadata": {}, "score": "67.556335"}
{"text": "6472 XDR tuberculosis is caused by M. tuberculosis resistant to rifampin and isoniazid ( multiple - drug resistant strains ) that also are resistant to a fluoroquinolone and at least one parenteral second - line antimycobacterial ( capreomycin , kanamycin , amikacin ) .", "label": "", "metadata": {}, "score": "67.59915"}
{"text": "PubMed View Article .Mannino DM , Buist AS : Global burden of COPD : risk factors , prevalence , and future trends .Lancet 2007 , 370 ( 9589 ) : 765 - 773 .", "label": "", "metadata": {}, "score": "67.60446"}
{"text": "Philadelphia : Elsevier ; 2005;927 - 951 .[PubMed ] [ DOI ] .Goulis J , Patch D , Burroughs AK .Bacterial infection in the pathogenesis of variceal bleeding .", "label": "", "metadata": {}, "score": "67.693436"}
{"text": "[ PubMed 16469488 ] .Gandhi NR , Moll A , Sturm AW et al .Extensively drug - resistant tuberculosis as a cause of death in patients co - infected with tuberculosis and HIV in a rural area of South Africa .", "label": "", "metadata": {}, "score": "67.77678"}
{"text": "View Article PubMed .Bourbeau J , Bartlett SJ : Patient adherence in COPD .Thorax 2008 , 63 : 831 - 838 .View Article PubMed .", "label": "", "metadata": {}, "score": "67.85313"}
{"text": "Changes in St George 's Respiratory Questionnaire ( SGRQ ) symptom scores .Values show change from baseline to Week 48 in activity and impact subscores for the per - protocol end - of - treatment ( PP EOT ) and intent - to - treat ( ITT ) populations Table S7 .", "label": "", "metadata": {}, "score": "67.90561"}
{"text": "viridans each in 2 ( 8 % ) , Pneumococci and S. aureus each in 1 ( 4 % )( Figure 1A ) .There were 6 ascitic fluid culture positive cases within group II ( out of 19 ) ; the isolated organisms were E. coli in 2 ( 33 % ) , Enterobacter , S. aureus , Enterococci and Acinetobacter each in one ( 16 % )", "label": "", "metadata": {}, "score": "67.950134"}
{"text": "Aerobic Gram - Positive Microorganisms : Staphylococcus aureus ( methicillin - susceptible strains only ) , Streptococcus pneumoniae ( including penicillin - resistant strains ) , Streptococcus pyogenes .", "label": "", "metadata": {}, "score": "67.95728"}
{"text": "Gut Liver .[PubMed ] [ DOI ] .Pfaller MA , Jones RN .A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide .", "label": "", "metadata": {}, "score": "67.995316"}
{"text": "Over one - half of patients ( 53.9 % ) were past or current smokers .Over the past 12 months , patients had experienced a mean of 2.7 \u00b1 1.9 ( range 1.0 - 20.0 ) episodes of AECB .", "label": "", "metadata": {}, "score": "68.016624"}
{"text": "Study design .PULSE was a randomized , double - blind , placebo - controlled , parallel group , multicentre international clinical trial that was conducted at 76 centres in 15 countries .", "label": "", "metadata": {}, "score": "68.01805"}
{"text": "Initiate prophylaxis as soon as possible following suspected or confirmed exposure to aerosolized B. anthracis .Optimum duration of postexposure prophylaxis after an inhalation exposure to B. anthracis spores unclear .", "label": "", "metadata": {}, "score": "68.17676"}
{"text": "Hospitalizations for PID declined steadily throughout the 1980s and 1990s but remained relatively constant between 2000 and 2006 , at approximately 80,000 annually .PID is co - epidemic with HIV among some urban populations of reproductive age .", "label": "", "metadata": {}, "score": "68.219864"}
{"text": "[ IDIS 471910 ] [ PubMed 11699843 ] .Inglesby TV , Dennis DT , Henderson DA et al for the Working Group on Civilian Biodefense .", "label": "", "metadata": {}, "score": "68.29671"}
{"text": "Immune reconstitution inflammatory syndrome ( IRIS ) has not been described in association with bacterial respiratory disease and treatment with ART in HIV - infected patients .", "label": "", "metadata": {}, "score": "68.37117"}
{"text": "Written informed consents were obtained from all patients .For patients with any grade of hepatic encephalopathy , the written informed consents were obtained from the first degree relatives .", "label": "", "metadata": {}, "score": "68.37482"}
{"text": "[PubMed ] [ DOI ] .Horinek E , Fish D. Spontaneous bacterial peritonitis .AACN Adv Crit Care .2009 ; 20 : 121 - 125 ; quiz 127 .", "label": "", "metadata": {}, "score": "68.38211"}
{"text": "Wilkinson TM , Patel IS , Wilks M , Donaldson GC , Wedzicha JA : Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "68.50972"}
{"text": "Prothrombin decrease ( prothrombin time prolonged / Internationl Normalized Ration ( INR ) increased ) , thrombocythemia , thrombocytopenia , eosinophilia , leukopenia .Metabolic and Nutritional : Amylase increased , lactic dehydrogenase increased .", "label": "", "metadata": {}, "score": "68.62965"}
{"text": "Noninvasive measurement of arterial oxygen saturation via pulse oximetry is an appropriate screening test .Arterial blood gas analysis is indicated for those with evidence of hypoxemia suggested by noninvasive assessment and for patients who have tachypnea and/or respiratory distress .", "label": "", "metadata": {}, "score": "68.63995"}
{"text": "Change from baseline in St George 's Respiratory Questionnaire ( SGRQ ) total scores .Scores are shown for each visit for those patients in the per - protocol end - of - treatment ( PP EOT ) and intent - to - treat ( ITT ) populations who provided SGRQ data .", "label": "", "metadata": {}, "score": "68.64772"}
{"text": "In Macedonia , no ethics committee approval or notification was requested at national level .All patients provided informed consent in accordance with local regulations .", "label": "", "metadata": {}, "score": "68.65223"}
{"text": "412 Role of long - term anti - infective treatment ( secondary prophylaxis ) in HIV - infected individuals with recurrent bacteremia not well established ; weigh benefits of such prophylaxis against risks of long - term anti - infective therapy .", "label": "", "metadata": {}, "score": "68.72313"}
{"text": "In : Goldman L , Ausiello D , eds .Cecil Medicine ; 23rd edition .Philadelphia : Saunders Elsevier ; 2007 .Handsfield HH , Sparling PF .", "label": "", "metadata": {}, "score": "68.747986"}
{"text": "Risk of QT interval prolongation may be increased in geriatric patients . 1 ( See Geriatric Use under Cautions . )Use with caution in patients with mild , moderate , or severe liver cirrhosis . 1 ( See Hepatic Impairment under Cautions . )", "label": "", "metadata": {}, "score": "68.762215"}
{"text": "Patients .The diagnosis of AECB and of any concomitant diseases was provided by attending physicians , who were pulmonologists or internal medicine specialists ( approximately 60 % ) , general practitioners ( 10 % ) , or practitioners from other specialties .", "label": "", "metadata": {}, "score": "68.831726"}
{"text": "Correlation of sputum culture with Gram stain can help in interpretation of sputum culture data .For intubated patients , an endotracheal aspirate sample should be obtained .", "label": "", "metadata": {}, "score": "68.992004"}
{"text": "Also reflecting current clinical experience , a large proportion of the patients had an underlying respiratory condition ( e.g. COPD , emphysema , or asthma ) .", "label": "", "metadata": {}, "score": "69.01683"}
{"text": "Jul 11 2005;165(13):1533 - 1540 .Osmond DH , Chin DP , Glassroth J , et al .Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression .", "label": "", "metadata": {}, "score": "69.25333"}
{"text": "Importance of women informing clinicians if they are or plan to become pregnant or plan to breast - feed .Importance of advising patients of other important precautionary information . 1 ( See Cautions . )", "label": "", "metadata": {}, "score": "69.28567"}
{"text": "Definitions .Cirrhosis : Cirrhosis diagnosed based on clinical , biochemical , histological and/or radiological findings and Child class was assessed for each patient .Exclusion criteria : ( 1 ) Non - cirrhotic ascites ( including malignant ascites ) ; ( 2 ) Cases with secondary bacterial peritonitis ; and ( 3 ) Bacterascites ( i.e .", "label": "", "metadata": {}, "score": "69.306694"}
{"text": "The study protocol was approved by the local independent ethics committee or institutional review board , as applicable , at each of the investigator sites .", "label": "", "metadata": {}, "score": "69.41271"}
{"text": "The incidence of H. influenzae type b infection in HIV - infected adults is low .Therefore , H. influenzae type vaccine is not usually recommended for adult use ( BIII ) unless a patient also has anatomic or functional asplenia .", "label": "", "metadata": {}, "score": "69.42914"}
{"text": "Elevated erythrocyte sedimentation rate ( ESR ) .Elevated C - reactive protein ( CRP ) .Laboratory documentation of cervical infection with GC or CT ( the absence of infection from the lower genital tract , where samples are usually obtained , does not exclude PID and should not influence the decision to treat ) .", "label": "", "metadata": {}, "score": "69.47869"}
{"text": "11 , 2016 Health 2.0 , the premiere ... technologies , announced today \" 10 Year Global Retrospective \" , ... over the past ten years . ...", "label": "", "metadata": {}, "score": "69.502075"}
{"text": "PubMed View Article .Kanner RE , Anthonisen NR , Connett JE : Lower respiratory illnesses promote FEV(1 ) decline in current smokers but not ex - smokers with mild chronic obstructive pulmonary disease : results from the lung health study .", "label": "", "metadata": {}, "score": "69.516754"}
{"text": "AC participated in study design , data acquisition , and data analysis and interpretation .MZ , DD , MT , and H - PM participated in data acquisition and data analysis and interpretation .", "label": "", "metadata": {}, "score": "69.62355"}
{"text": "Key Diagnostic Testing Markets .- Molecular Diagnostics ...Testing . - Molecular Diagnostics in Infectious Disease Testing . ...Products World Markets .- Point of Care Diagnostic ... .", "label": "", "metadata": {}, "score": "69.814896"}
{"text": "Peripheral Neuropathy Rare cases of sensory or sensorimotor axonal polyneuropathy affecting small and/or large axons resulting in paresthesias , hypoesthesias , dysesthesias and weakness have been reported in patients receiving quinolones .", "label": "", "metadata": {}, "score": "69.92517"}
{"text": "View Article PubMed .Bhowmik A , Seemungal TA , Sapsford RJ , Wedzicha JA : Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations .", "label": "", "metadata": {}, "score": "69.94377"}
{"text": "[PubMed ] [ DOI ] .Ahmad M , Ali AA , Mumtaz M , Iqbal J , Mughal AA .Spontaneous bacterial peritonitis ; Microbiological analysis of ascitic fluid in patients with complicated liver cirrhosis .", "label": "", "metadata": {}, "score": "70.20016"}
{"text": "[ PubMed 17277290 ] .Centers for Disease Control and Prevention .Update : investigation of anthrax associated with intentional exposure and interim public health guidelines , October 2001 .", "label": "", "metadata": {}, "score": "70.21367"}
{"text": "[ IDIS 407213 ] [ PubMed 9659970 ] .Baddour LM , Wilson WR , Bayer AS et al .Circulation .2005 ; 111:e394 - 433 .", "label": "", "metadata": {}, "score": "70.28053"}
{"text": "Body as a Whole : .Headache , abdominal pain , injection site reaction , asthenia , moniliasis , pain , malaise , lab test abnormal ( not specified ) , allergic reaction , leg pain , back pain , chest pain .", "label": "", "metadata": {}, "score": "70.461395"}
{"text": "MST was the Study Manager for Bayer Healthcare .All authors contributed significantly to the development of the manuscript , and all have all seen and approved the final version and take responsibility for the content .", "label": "", "metadata": {}, "score": "70.55171"}
{"text": "Exacerbation of Myasthenia Gravis .May exacerbate muscle weakness in myasthenia gravis patients ; 1 death or need for ventilatory support reported .Sensitivity Reactions .", "label": "", "metadata": {}, "score": "71.05438"}
{"text": "When the latter method is used , the P. carinii particles show up as dark , ovoid shapes against a blue- green background .Current treatment recommendations .", "label": "", "metadata": {}, "score": "71.17201"}
{"text": "Cervical motion tenderness , or .Uterine tenderness , or .Adnexal tenderness .The following signs support a diagnosis of PID : .Abnormal cervical or vaginal mucopurulent discharge .", "label": "", "metadata": {}, "score": "71.18418"}
{"text": "\"A significant number of pediatric ADHD patients present with behaviors such as anger , resentfulness , defiance , and arguing with adults .It can be complicated for physicians and caregivers to find the right medication to control symptoms for children with ADHD exhibiting these behaviors , \" said Daniel Connor , MD , professor and division chief of child and adolescent psychiatry at the University of Connecticut Medical School .", "label": "", "metadata": {}, "score": "71.20326"}
{"text": "Birring SS , Brightling CE , Bradding P , Entwisle JJ , Vara DD , Grigg J , Wardlaw AJ , Pavord ID : Clinical , radiologic , and induced sputum features of chronic obstructive pulmonary disease in nonsmokers : a descriptive study .", "label": "", "metadata": {}, "score": "71.24454"}
{"text": "PP EOT , per - protocol end - of - treatment ; ITT , intent - to - treat .Table S1 .Analysis of pre - specified subgroups .", "label": "", "metadata": {}, "score": "71.28813"}
{"text": "International Ascites Club .J Hepatol .[PubMed ] [ DOI ] .Hoefs JC .Spontaneous bacterial peritonitis : prevention and therapy .Hepatology .", "label": "", "metadata": {}, "score": "71.31807"}
{"text": "ADHD is one of the most common psychiatric disorders in children and adolescents .Worldwide prevalence of ADHD is estimated at 5.3 percent ( with large variability ) , according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry .", "label": "", "metadata": {}, "score": "71.436676"}
{"text": "In HIV - infected individuals , as in those who are not HIV infected , Streptococcus pneumoniae and Haemophilus species are the most frequently identified causes of community - acquired bacterial pneumonia .", "label": "", "metadata": {}, "score": "71.65183"}
{"text": "[PubMed ] [ DOI ] .European Association for the Study of the Liver .EASL clinical practice guidelines on the management of ascites , spontaneous bacterial peritonitis , and hepatorenal syndrome in cirrhosis .", "label": "", "metadata": {}, "score": "71.75564"}
{"text": "World J Gastroenterol 2013 ; 19(8 ) : 1271 - 1277 .Spontaneous bacterial peritonitis ( SBP ) is infection of ascitic fluid in cirrhotic patients .", "label": "", "metadata": {}, "score": "71.82321"}
{"text": "The first set of p - values on the graphs are from logistic regression analysis using the median value for patients missing at 48 weeks .", "label": "", "metadata": {}, "score": "71.883835"}
{"text": "Forced expiratory volume in 1 second .Declarations .Acknowledgments .Bayer Pharma provided support in the design and conduct of the study and in the collection , management , and analysis of the data .", "label": "", "metadata": {}, "score": "71.90105"}
{"text": "Assessments : Daily assessments are performed double - blind at 0 , 1 , 2 , 3 , 4 , 5 , 6 , 7 and 14 days .", "label": "", "metadata": {}, "score": "72.061264"}
{"text": "2007 ; 44 Suppl 2:S27 - 72 .[ PubMed 17278083 ] .Malangoni MA , Song J , Herrington J et al .", "label": "", "metadata": {}, "score": "72.08006"}
{"text": "Pulmonology Department .Klinika za Pulmologija i Alergologija .Privatna Pulmolo\u0161ka Ordinacija \" Dr. Toki\u0107 \" .Bayer Vital GmbH .Bayer Pharma AG .References .", "label": "", "metadata": {}, "score": "72.15654"}
{"text": "In this parent - rated scale , numerous symptoms including anger , defiance , arguing with adults , and loss of temper were assessed in children on a four - point scale and a higher score indicated greater problems .", "label": "", "metadata": {}, "score": "72.18001"}
{"text": "Standard treatments include educational approaches , psychological , or behavioral modification , and medication .( Date:2/12/2016 ) ... ...February 12 , 2016 , ... Fisher House Foundation Chairman and ...", "label": "", "metadata": {}, "score": "72.28035"}
{"text": "Staphylococcus spp . , Escherichia coli , Enterococcus spp . , Enterobacter spp . , K. pneumoniae , P. aeruginosa and Candida spp . were isolated from the rectal swab cultures .", "label": "", "metadata": {}, "score": "72.367004"}
{"text": "AC , MZ , DD , and MT declare that they have no competing interests .H - PM and TP are full - time employees of Bayer AG .", "label": "", "metadata": {}, "score": "73.17129"}
{"text": "View Article PubMed .Hogg JC : Infection and COPD .Exp Lung Res 2005 , 31 ( Suppl 1 ) : 72 - 73 .", "label": "", "metadata": {}, "score": "73.41945"}
{"text": "Aug 6 2010;59(RR-8):1 - 62 .Anglaret X , Chene G , Attia A , et al .Early chemoprophylaxis with trimethoprim - sulphamethoxazole for HIV-1-infected adults in Abidjan , Cote d'Ivoire : a randomised trial .", "label": "", "metadata": {}, "score": "73.473976"}
{"text": "[PubMed ] [ DOI ] .El - Bendary MM , Abdel - Aziz M , El - Sherbiny WA , Farag RE , El - Gilany A , Zaghloul MH .", "label": "", "metadata": {}, "score": "73.51944"}
{"text": "Declarations .Acknowledgements .This study was supported by a research grant from Bayer HealthCare AG .Highfield Communication Consultancy ( funded by Bayer HealthCare AG ) and Bayer HealthCare AG provided editorial assistance in the preparation of this manuscript .", "label": "", "metadata": {}, "score": "73.708626"}
{"text": "24 As discussed in the Diagnosis section , if specimens are to be collected for diagnosis , they should be taken before antibiotic therapy is initiated .", "label": "", "metadata": {}, "score": "73.75622"}
{"text": "Endometrial biopsy with histopathologic evidence of endometritis .Transvaginal sonogram or other imaging showing thickened , fluid - filled tubes with or without free pelvic fluid or tubo - ovarian complex .", "label": "", "metadata": {}, "score": "74.03431"}
{"text": "Discontinue if pain , swelling , inflammation , or rupture of a tendon occurs . 1 128 129 Advise patients to rest and refrain from exercise and contact a clinician at the first sign of tendinitis or tendon rupture ( e.g. , pain , swelling , or inflammation of a tendon or weakness or inability to use a joint ) .", "label": "", "metadata": {}, "score": "74.258385"}
{"text": "Convulsions and neuropsychiatric complications Convulsions have been reported in patients receiving quinolones .Quinolones may also cause central nervous system ( CNS ) events including : dizziness , confusion , tremors , hallucinations , depression , and , rarely , suicidal thoughts or acts .", "label": "", "metadata": {}, "score": "74.402115"}
{"text": "Individual symptoms and signs of sputum volume , fever , cough , dyspnea , and sputum character resolved or improved in the majority of patients ( range 77 - 89 % ) during the observational period .", "label": "", "metadata": {}, "score": "74.428604"}
{"text": "Skin and Skin Structure Infections .Treatment of uncomplicated skin and skin structure infections ( abscesses , furuncles , cellulitis , impetigo ) caused by susceptible S. aureus ( oxacillin - susceptible [ methicillin - susceptible ] strains ) or S. pyogenes ( group A \u03b2 - hemolytic streptococci ) .", "label": "", "metadata": {}, "score": "74.66014"}
{"text": "Ascitic fluid cultures were performed at the time of the initial paracentesis in the blood culture bottles ( Remaux , France ) at the bedside .", "label": "", "metadata": {}, "score": "75.03422"}
{"text": "Distribution .Extent .Widely distributed into body tissues and fluids , including saliva , nasal and bronchial secretions , sinus mucosa , skin blister fluid , subcutaneous tissue , skeletal muscle , and abdominal tissues and fluids .", "label": "", "metadata": {}, "score": "75.09296"}
{"text": "Competing interests .Sanjay Sethi has received research grants ( 26,000 USD ) from Bayer HealthCare and honoraria for attendance at advisory boards and speaking work ( 23,000 USD ) over the last 3 years .", "label": "", "metadata": {}, "score": "75.41347"}
{"text": "Background .The morbidity and mortality of chronic obstructive pulmonary disease ( COPD ) is substantially contributed to by frequent acute exacerbations of the disease .", "label": "", "metadata": {}, "score": "75.42284"}
{"text": "Changes in St George 's Respiratory Questionnaire symptom subscale scores .Baseline bacteriology .Sputum isolates .Relevant respiratory pathogens were isolated at randomization from about 24 % of all patients .", "label": "", "metadata": {}, "score": "75.68951"}
{"text": "Adequate . diagnosis requires the use of medical and special psychological , educational and social resources , utilizing diagnostic criteria such as Diagnostic and Statistical Manual of Mental Disorders - IV ( DSM - IV ) or International Classification of Diseases 10 ( ICD-10 ) .", "label": "", "metadata": {}, "score": "75.69644"}
{"text": "Those with clinical and radiographic findings suggestive of TB should be managed as potentially having TB ( that is , with respiratory isolation if hospitalized ) , and two to three sputum specimens should be obtained for acid fast bacilli evaluation .", "label": "", "metadata": {}, "score": "75.84289"}
{"text": "Mar 1998;26(3):611 - 619 .Crothers K , Griffith TA , McGinnis KA , al e. The impact of cigarette smoking on mortality , quality of life , and comorbid illness among HIV - positive veterans .", "label": "", "metadata": {}, "score": "75.86729"}
{"text": "22 They are often febrile and the presence of fever , tachycardia , or hypotension can be an indicator of sepsis .Tachypnea and decreased arterial oxygen saturation indicate moderate - to - severe pneumonia and clinicians should strongly consider hospitalizing such patients .", "label": "", "metadata": {}, "score": "75.96258"}
{"text": "After a single episode of PID , a woman 's risk of ectopic pregnancy increases sevenfold .Approximately 13 % of women are infertile after a single episode of PID , 25 - 35 % after two episodes , and 50 - 75 % after three or more episodes .", "label": "", "metadata": {}, "score": "76.01398"}
{"text": "Check vital signs with special attention to temperature ( may be elevated or normal ) .Perform a focused physical examination .Check abdomen ( bowel sounds , distention , rebound , guarding , masses , suprapubic and costovertebral angle [ CVA ] tenderness ) ; perform complete pelvic examination looking for abnormal bleeding or discharge ; uterine , adnexal , or cervical motion tenderness ; pelvic masses or adnexal enlargement .", "label": "", "metadata": {}, "score": "76.62375"}
{"text": "Southern Nevada Healthcare System .This will be the first Fisher House in Nevada , ... .( Date:2/12/2016 ) ... ... ...Vail knee specialist Robert LaPrade , MD , PhD was named one of ... of physicians establishing , leading and partnering with ambulatory surgery centers across the United States . ... also known as an ASC , is a modern health care facility focused on providing ... .", "label": "", "metadata": {}, "score": "76.7988"}
{"text": "All authors participated in the critical review revision of the manuscript .All authors read and approved the final manuscript for submission .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "77.09783"}
{"text": "In contrast , lung examination often is normal in those with Pneumocystis pneumonia ( PCP ) , and if abnormal , reveals inspiratory crackles .In patients with bacterial pneumonia , the white blood cell ( WBC ) count usually is elevated .", "label": "", "metadata": {}, "score": "77.10239"}
{"text": "AECB : .Acute exacerbation of chronic bronchitis .AECOPD : .Acute exacerbation of chronic obstructive pulmonary disease .COPD : .Chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "77.264725"}
{"text": "A diagnosis of PID usually is based on clinical findings ; however , the following can support a diagnosis and help rule out other causes of abdominal pain : .", "label": "", "metadata": {}, "score": "77.33101"}
{"text": "Diverticulitis .Irritable bowel syndrome .Cystitis .Uterine fibroids / leiomyomas .Ovarian torsion .Mittelschmerz .Kidney stones .Pyelonephritis .P : Plan .", "label": "", "metadata": {}, "score": "77.4032"}
{"text": "1 Tendinitis and tendon rupture in the rotator cuff ( shoulder ) , hand , biceps , thumb , and other tendon sites also reported .", "label": "", "metadata": {}, "score": "77.60206"}
{"text": "Jadwiga A. Wedzicha has received research grants ( 40,000 USD ) from Bayer HealthCare and honoraria for attendance at advisory boards ( 10,000 USD ) .", "label": "", "metadata": {}, "score": "77.62561"}
{"text": "Pre - specified protocol violations resulted in patients being excluded from the per - protocol ( PP ) population ( see Additional file 2 : Pre - specified protocol violations ) .", "label": "", "metadata": {}, "score": "77.70889"}
{"text": "In : Mandell GL , Bennett JE , Dolin R , eds .Mandell , Douglas , and Bennett 's Principles and Practice of Infectious Diseases .", "label": "", "metadata": {}, "score": "77.85981"}
{"text": "PubMed ] [ DOI ] .Rimola A , Garc\u00eda - Tsao G , Navasa M , Piddock LJ , Planas R , Bernard B , Inadomi JM .", "label": "", "metadata": {}, "score": "78.40616"}
{"text": "Marlize Schmitt Theron is a salaried employee of Bayer Pty Ltd. .Marc Miravitlles has received honoraria ( total 11,000 USD ) from Bayer HealthCare AG for consultancy and speaking work over the last two years .", "label": "", "metadata": {}, "score": "78.48764"}
{"text": "from inhibition of the topoisomerase II ( DNA gyrase ) and topoisomerase IV required for bacterial DNA replication , transcription , repair , and recombination .", "label": "", "metadata": {}, "score": "78.67889"}
{"text": "Sputum samples were collected from all patients at all clinic visits and were processed locally for Gram stain and culture .For the following organisms , defined in the protocol as potential respiratory pathogens in COPD , moxifloxacin susceptibility testing was performed locally by E - test : Haemophilus influenzae , Haemophilus parainfluenzae , Streptococcus pneumoniae , Moraxella catarrhalis , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Staphylococcus aureus .", "label": "", "metadata": {}, "score": "79.09682"}
{"text": "Figure 1 Isolated organisms in groups .A : Group I ; B : Group II . E. coli : Escherichia coli .Ascitic fluid analysis .", "label": "", "metadata": {}, "score": "79.69934"}
{"text": "View Article PubMed .American Thoracic Society / European Respiratory Society Task Force : Standards for the Diagnosis and Management of Patients with COPD [Internet].", "label": "", "metadata": {}, "score": "79.84049"}
{"text": "Correspondence to : Dr. Mohamed Hassan Emara , MD , Department of Tropical Medicine , Zagazig University Faculty of Medicine , Zagazig 44519 , Egypt .", "label": "", "metadata": {}, "score": "79.90903"}
{"text": "The isolated organisms found in group II were ; enterococci , acinetobacter , expanded - spectrum \u03b2 - lactamase producing Escherichia coli , \u03b2 - lactamase producing Enterobacter and Staphylococcus aureus .", "label": "", "metadata": {}, "score": "80.29054"}
{"text": "[ IDIS 471389 ] [ PubMed 11686472 ] .Centers for Disease Control and Prevention .Update : investigation of bioterrorism - related anthrax and interim guidelines for exposure management and antimicrobial therapy , October 2001 .", "label": "", "metadata": {}, "score": "80.40536"}
{"text": "[PubMed ] [ DOI ] .Sun L , Zhang JV , Zhao J , Bai WT , Huang CX , Jia ZS , Lian JQ , Sun YT .", "label": "", "metadata": {}, "score": "80.558426"}
{"text": "Allocation : Randomized Endpoint Classification : Efficacy Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Investigator )Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "80.902916"}
{"text": "It is thought that PID generally is caused by sexually transmitted diseases ( STDs ) and that additional organisms become involved after infection spreads and protective immunological barriers are disrupted .", "label": "", "metadata": {}, "score": "80.929306"}
{"text": "ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity - impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development .", "label": "", "metadata": {}, "score": "81.255844"}
{"text": "Fundaci\u00f3 Cl\u00ednic , Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer ( IDIBAPS ) .Section of Infectious Diseases , University of Manitoba Faculty of Medicine .", "label": "", "metadata": {}, "score": "81.26811"}
{"text": "Data were checked , entered and analyzed using SPSS Version 15 .Data were expressed as mean \u00b1 SD for quantitative variables , number and percentage for qualitative ones .", "label": "", "metadata": {}, "score": "81.29834"}
{"text": "Gram - negative aerobes : Active in vitro and in clinical infections against Enterobacter cloacae , 1 Escherichia coli , 1 24 H. influenzae , 1 24 H. parainfluenzae , 1 K. pneumoniae , 1 M. catarrhalis , 1 and Proteus mirabilis . 1 Active against Y. pestis in vitro and in a primate infection model . 1 Also active in vitro against Citrobacter freundii , 1 24 K. oxytoca , 1 and Legionella pneumophila .", "label": "", "metadata": {}, "score": "81.3129"}
{"text": "Values are MICs ( numbers ) for bacteria isolated from the sputum and rectal swab samples of moxifloxacin- or placebo - treated patients in the per - protocol end - of - treatment ( PP EOT ) population at each study visit .", "label": "", "metadata": {}, "score": "81.45935"}
{"text": "Dr Wilson has also appeared as an expert witness for Bayer Healthcare AG .Authors ' contributions .SS was the main author of the paper and undertook the initial drafting and assessment of data .", "label": "", "metadata": {}, "score": "81.61301"}
{"text": "Black N : Why we need observational studies to evaluate the effectiveness of health care .BMJ 1996 , 312 ( 7040 ) : 1215 - 1218 .", "label": "", "metadata": {}, "score": "81.86578"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "81.93963"}
{"text": "Erratum in : Eur Respir J 2003 , 21 : 74 - 81 View Article PubMed .Lancet 2003 , 361 : 449 - 456 .", "label": "", "metadata": {}, "score": "82.319885"}
{"text": "Study population .A CONSORT flow diagram charts the disposition of patients throughout the study ( Figure 1 ) .A total of 1404 eligible patients were enrolled .", "label": "", "metadata": {}, "score": "82.6635"}
{"text": "This article was provided by San Francisco General Hospital .It is a part of the publication HIV Newsline .It is not a substitute for professional care .", "label": "", "metadata": {}, "score": "82.80435"}
{"text": "The assessment of sputum purulence was made by the investigator based on patient report of colour of sputum .Statistical analysis .Continuous demographic variables were analysed using two - way analysis of variance ( ANOVA ) and categorical demographic variables by a Cochran - Mantel - Haenszel test .", "label": "", "metadata": {}, "score": "83.13483"}
{"text": "Updated Sections .The Syphilis and Candida sections has been updated !For a summary of changes , see the What 's New section .Search Term .", "label": "", "metadata": {}, "score": "83.49811"}
{"text": "PubMed ] [ DOI ] .Heo J , Seo YS , Yim HJ , Hahn T , Park SH , Ahn SH , Park JY , Park JY , Kim MY , Park SK .", "label": "", "metadata": {}, "score": "83.92854"}
{"text": "Previously categorized as a protozoan and now classified as a fungus , P. carinii can be isolated from the environment by means of a spore trap and identified by polymerase chain- reaction assay .", "label": "", "metadata": {}, "score": "84.08778"}
{"text": "At each visit , spirometry was performed and disease - related health status was assessed by using the St George 's Respiratory Questionnaire ( SGRQ ) .", "label": "", "metadata": {}, "score": "84.28798"}
{"text": "New York : Churchill Livingstone ; 2010 .Trigg BG , Kerndt PR , Aynalem G. Sexually transmitted infections and pelvic inflammatory disease in women .", "label": "", "metadata": {}, "score": "85.22513"}
{"text": "Treatment of plague , including pneumonic and septicemic plague , caused by Yersinia pestis .292 538 683 688 Regimens recommended for treatment of naturally occurring or endemic bubonic , septicemic , or pneumonic plague also recommended for plague that occurs following exposure to Y. pestis in the context of biologic warfare or bioterrorism .", "label": "", "metadata": {}, "score": "85.3691"}
{"text": "MATERIALS AND METHODS .Study design .This prospective study was conducted at the Tropical Medicine Department , Zagazig University Hospitals , Zagazig , Sharkia Governorate , Egypt during the period from October 2010 to October 2011 .", "label": "", "metadata": {}, "score": "85.82146"}
{"text": "Central Nervous System : .Insomnia , nervousness , anxiety , confusion , somnolence , tremor , vertigo , paresthesia .Digestive : .Vomiting , diarrhoea , abnormal liver function test , dyspepsia , dry mouth , constipation , oral moniliasis , anorexia , stomatitis , glossitis , flatulence , gastrointestinal disorder , GGTP increased .", "label": "", "metadata": {}, "score": "87.45436"}
{"text": "Ahmed Abouelkhair Badawy , Tarik Ibrahim Zaher , Samar Mahmoud Sharaf , Mohamed Hassan Emara , Noha Elsaid Shaheen , Talaat Fathy Aly .Ahmed Abouelkhair Badawy , Tarik Ibrahim Zaher , Mohamed Hassan Emara , Noha Elsaid Shaheen , Talaat Fathy Aly , Department of Tropical Medicine , Zagazig University Faculty of Medicine , Zagazig 44519 , Egypt .", "label": "", "metadata": {}, "score": "87.69364"}
{"text": "Respiratory Medicine , Royal Brompton Hospital .References .Kanner RE , Anthonisen NR , Connett JE , Lung Health Study Research Group : Lower respiratory illnesses promote FEV 1 decline in current smokers but not ex - smokers with mild chronic obstructive pulmonary disease .", "label": "", "metadata": {}, "score": "88.626526"}
{"text": "Type your search term(s ) in the text box .Users can only search one guideline at a time .To search for an exact phrase , use quotation marks ( i.e. \" what to start \" ) .", "label": "", "metadata": {}, "score": "91.61244"}
{"text": "All rights reserved .World J Gastroenterol .Feb 28 , 2013 ; 19(8 ) : 1271 - 1277 Published online Feb 28 , 2013 . doi : 10.3748/wjg.v19.i8.1271 .", "label": "", "metadata": {}, "score": "93.006996"}
{"text": "Our Team , headed by Mike Cadogan & Chris Nickson , consists ( mostly ) of emergency physicians and intensivists based in Australia and New Zealand .", "label": "", "metadata": {}, "score": "93.52652"}
{"text": "February 12 , 2016 , ... Donor Network West , the organ procurement organization that ... partnership with San Ramon Regional Medical Center .Under the collaboration , the first of its ... to accommodate a more certain time frame for donor families for the recovery of ... .", "label": "", "metadata": {}, "score": "93.5885"}
{"text": "Pre - publication history .Copyright .\u00a9 Chuchalin et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "93.8757"}
{"text": "Pelvic Inflammatory Disease .Background .Pelvic inflammatory disease ( PID ) is the syndrome resulting from the ascent of microorganisms from the vagina and cervix to the uterine endometrium , fallopian tubes , ovaries , or contiguous abdominal structures .", "label": "", "metadata": {}, "score": "96.384735"}
{"text": "Received : September 14 , 2012 Revised : October 16 , 2012 Accepted : November 11 , 2012 Published online : February 28 , 2013 .", "label": "", "metadata": {}, "score": "99.48717"}
{"text": "Land , TX ( PRWEB ) , ... February 12 , 2016 ... ... families of southwest Houston and surrounding communities by continuing it 's commitment to act ...", "label": "", "metadata": {}, "score": "102.05794"}
{"text": "Division of Pulmonary , Critical Care and Sleep Medicine , University of Buffalo , State University of New York .Division of Cardiac and Vascular Services , St George 's , University of London .", "label": "", "metadata": {}, "score": "103.55487"}
{"text": "The prefrontal cortex is an area of the brain associated with working memory , behavioral inhibition , regulation of attention , distractibility , and impulsivity .", "label": "", "metadata": {}, "score": "108.70097"}
{"text": "[PubMed ] [ DOI ]", "label": "", "metadata": {}, "score": "170.75421"}
